data_2lb1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lb1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.759 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.659 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.788 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.556 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.556 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.788 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.759 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.666 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 27.1 m170 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.845 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.845 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 306' ' ' THR . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.858 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.406 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.49 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.778 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.885 HG22 HD13 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.903 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.885 HD13 HG22 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.903 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.706 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 21.3 m170 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.562 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.578 ' OD2' HD11 ' A' ' 313' ' ' LEU . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.621 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' OD2' ' A' ' 310' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.501 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.563 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.568 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.706 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.616 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.734 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.404 HD21 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.524 -0.547 . . . . 15.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.425 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.745 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.664 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.513 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.555 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.427 HG23 HH11 ' A' ' 289' ' ' ARG . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.745 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.664 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.3 m170 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.425 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.636 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.2 mm100 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.482 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.482 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.54 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.594 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.737 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.624 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.539 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.516 ' H ' ' NE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.75 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.691 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.849 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.849 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.75 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 17.7 m170 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.767 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.476 ' HB2' HD13 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.457 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.491 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.604 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.49 ' H ' HG13 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.573 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.463 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.542 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.492 -0.558 . . . . 15.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' B' ' 230' ' ' PRO . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' THR . . . . . 0.556 HG22 ' NH1' ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.504 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.438 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.58 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.58 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.724 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.529 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.676 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.45 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.439 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.746 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.69 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.746 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.649 ' HB3' HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.672 ' HD2' ' CD1' ' B' ' 227' ' ' TYR . 7.8 m170 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.3 mm100 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.488 ' HD3' HD23 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.457 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.576 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.742 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.455 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.475 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.549 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.848 0.356 . . . . 15.0 110.102 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.724 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.589 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.977 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.607 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.977 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.681 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 50.6 m170 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.603 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 17.1 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.607 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.808 ' HD2' HD21 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.671 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.681 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.527 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.415 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.656 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.752 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.698 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 288' ' ' VAL . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 1.0 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.573 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 1.0 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.752 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.735 HG22 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.649 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.698 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 29.2 m170 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.453 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.766 HG23 HE22 ' A' ' 307' ' ' GLN . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.766 HE22 HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.653 ' OD2' HD11 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.656 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.653 HD11 ' OD2' ' A' ' 310' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.553 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.608 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.602 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.253 -0.277 . . . . 15.0 110.253 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.735 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.667 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.661 HG22 HD12 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.942 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.661 HD12 HG22 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.942 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.735 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.741 HG22 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.557 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.667 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 34.9 m170 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.557 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.767 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.416 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.421 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.564 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.884 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.506 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.74 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.755 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.755 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.74 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 228' ' ' LEU . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.44 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.634 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 28.6 m170 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.44 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.562 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.476 ' O ' HG22 ' A' ' 306' ' ' THR . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.463 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.687 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.535 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp . . . . . 0 C--O 1.233 0.219 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.727 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.699 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.619 HG11 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.996 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.517 HD13 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.996 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.727 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.476 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.699 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.476 HG21 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.511 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.716 ' HD2' HD21 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.511 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.494 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.595 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.681 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.694 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.424 HG13 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' B' ' 230' ' ' PRO . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.674 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.681 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.694 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 20.3 m170 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.435 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.524 HE21 HG22 ' A' ' 309' ' ' THR . 40.2 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' THR . . . . . 0.524 HG22 HE21 ' A' ' 307' ' ' GLN . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.521 ' HD2' HD21 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.692 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.498 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.683 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.43 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.6 tp . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.485 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.748 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.685 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.478 HG23 HD12 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 1.018 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 1.018 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.748 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.685 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.562 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.871 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.871 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.643 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.871 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.673 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.721 0.296 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.779 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.759 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.642 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.627 HD13 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.642 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.779 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.791 HG22 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.759 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 9.3 m170 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.493 HD21 HG22 ' A' ' 305' ' ' THR . 7.9 t30 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.493 HG22 HD21 ' A' ' 303' ' ' ASN . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.619 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.496 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.614 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.614 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.54 ' HA ' HG11 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.622 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.702 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.973 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.973 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.758 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.533 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.702 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.533 HG21 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.88 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.436 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.66 ' HB3' HD23 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 312' ' ' ARG . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.457 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.65 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.472 ' H ' HG13 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.56 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.672 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.45 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.849 -0.426 . . . . 15.0 109.849 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 286' ' ' TRP . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.754 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.711 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.914 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.914 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.754 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.606 HG22 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.711 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.2 m170 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.501 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.9 mm-40 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.406 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.57 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.57 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.558 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.558 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.719 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.606 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.715 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 54.2 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.762 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.763 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 288' ' ' VAL . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.871 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.871 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.762 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.763 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.3 m170 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.744 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.559 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.494 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.744 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.8 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.529 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.245 -0.28 . . . . 15.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.746 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.711 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.832 ' HB ' HD13 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.906 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.832 HD13 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.906 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.746 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.64 ' CG1' ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.711 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 31.5 m170 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.515 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.64 ' HA ' ' CG1' ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.456 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.441 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.313 -0.625 . . . . 15.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.74 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.664 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.608 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.783 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 296' ' ' ILE . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.783 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.74 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.664 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 37.1 m170 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.736 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . 0.403 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.671 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.671 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.736 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.664 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.767 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.184 -0.302 . . . . 15.0 110.184 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.428 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.544 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.749 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLU . . . . . 0.751 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.976 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.976 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' PHE . . . . . 0.749 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' HIS . . . . . 0.751 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASN . . . . . 0.544 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 1.5 p30 -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.404 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.404 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' TYR . . . . . 0.654 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . 0.487 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' PRO . . . . . 0.504 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 289' ' ' ARG . 20.0 pt-20 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.578 HD22 ' H2 ' ' A' ' 279' ' ' LEU . 3.8 mm? . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.603 0.223 . . . . 15.0 111.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -165.34 -95.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.535 -1.317 . . . . 15.0 114.429 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -89.8 150.03 4.98 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.506 2.804 . . . . 15.0 114.825 -166.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp -108.51 118.02 53.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.507 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.759 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.659 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.788 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.556 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.556 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.788 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.759 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.858 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.666 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 27.1 m170 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.528 ' HB3' HD12 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.845 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.845 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.445 ' O ' HG22 ' A' ' 306' ' ' THR . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.858 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.406 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.49 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 -96.63 99.91 11.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 17.9 t70 -138.72 114.28 8.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 O-C-N 121.976 -0.452 . . . . 15.0 110.482 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.8 Cg_exo -78.41 84.58 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.905 2.403 . . . . 15.0 111.469 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.104 -0.498 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.02 0.438 . . . . 15.0 110.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -127.67 -127.83 3.05 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.579 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -91.77 149.02 3.34 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.558 2.838 . . . . 15.0 113.879 -175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp -91.64 107.7 24.06 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 167.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.778 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.885 HG22 HD13 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.903 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.885 HD13 HG22 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.903 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.706 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 21.3 m170 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.477 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.562 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.832 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.578 ' OD2' HD11 ' A' ' 313' ' ' LEU . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.621 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.578 HD11 ' OD2' ' A' ' 310' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.501 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.563 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.568 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.706 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.616 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.734 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.94 126.63 51.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.3 t70 -134.18 114.3 12.63 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.695 -0.628 . . . . 15.0 110.943 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -75.19 89.8 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.177 2.585 . . . . 15.0 112.073 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.404 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.937 -0.394 . . . . 15.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 156.41 -141.14 7.71 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.676 -1.249 . . . . 15.0 113.731 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -89.91 150.04 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.811 3.007 . . . . 15.0 114.128 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.404 HD21 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp -121.14 111.45 33.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.661 -0.7 . . . . 15.0 109.524 171.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.425 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.745 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.664 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.513 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.555 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.427 HG23 HH11 ' A' ' 289' ' ' ARG . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.595 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.555 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.745 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.664 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.3 m170 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.425 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.426 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.636 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.2 mm100 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.482 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.482 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.595 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.54 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.594 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.737 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.624 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.539 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.516 ' H ' ' NE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 -105.94 99.04 8.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 20.7 t70 -147.29 112.97 4.09 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 121.033 -1.042 . . . . 15.0 111.574 -169.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 3.4 Cg_exo -80.96 88.12 1.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.443 2.762 . . . . 15.0 111.658 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.168 -0.469 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.675 HD13 ' H3 ' ' A' ' 279' ' ' LEU . 7.1 mp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.458 0.171 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 141.05 -78.66 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.9 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -89.77 148.18 4.93 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.875 2.384 . . . . 15.0 114.023 -170.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp -113.83 113.31 47.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.56 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.75 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.691 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.849 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.849 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.75 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.585 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 17.7 m170 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.767 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.476 ' HB2' HD13 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.655 ' HA ' HD12 ' A' ' 279' ' ' LEU . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.457 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.491 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.604 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.49 ' H ' HG13 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.573 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.463 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.542 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 -125.66 117.8 24.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.07 108.52 3.23 Favored Pre-proline 0 C--O 1.234 0.256 0 O-C-N 121.717 -0.615 . . . . 15.0 110.745 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -95.19 67.65 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.254 2.636 . . . . 15.0 112.282 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 111.86 0.318 . . . . 15.0 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 154.4 -57.7 0.4 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.062 -1.542 . . . . 15.0 115.353 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.68 139.74 3.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.113 1.876 . . . . 15.0 114.599 -166.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp -101.38 117.55 61.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.085 -0.962 . . . . 15.0 109.492 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.839 HG21 HD13 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' B' ' 230' ' ' PRO . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.556 HG22 ' NH1' ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.471 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.504 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.438 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.58 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.58 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.527 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.724 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.529 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.676 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.45 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 -89.93 99.1 12.18 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.3 110.01 3.21 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 121.131 -0.98 . . . . 15.0 111.35 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.86 82.69 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.462 2.775 . . . . 15.0 112.027 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.435 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.447 ' H1 ' ' C ' ' A' ' 313' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 110.12 -0.326 . . . . 15.0 110.12 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 162.48 -56.32 0.3 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.911 -1.138 . . . . 15.0 114.128 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -89.66 148.16 5.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.204 1.936 . . . . 15.0 113.889 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.488 HD23 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp -114.7 119.66 39.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.347 -0.842 . . . . 15.0 109.441 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.439 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.746 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.69 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.746 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.742 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.649 ' HB3' HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.672 ' HD2' ' CD1' ' B' ' 227' ' ' TYR . 7.8 m170 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.3 mm100 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.488 ' HD3' HD23 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.457 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.576 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.742 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.455 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.475 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.549 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 -117.77 129.48 55.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.97 114.72 3.42 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 118.376 0.535 . . . . 15.0 110.069 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.76 -73.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.18 2.586 . . . . 15.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.478 -0.328 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.536 HD23 ' H3 ' ' A' ' 279' ' ' LEU . 2.1 pt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.837 0.351 . . . . 15.0 110.524 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -166.02 171.36 41.1 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.195 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -89.92 146.16 4.61 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.205 2.603 . . . . 15.0 112.822 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.808 HD21 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp -130.14 102.66 17.2 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.102 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.724 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.614 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.589 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.977 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.607 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.977 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.761 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.681 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 50.6 m170 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.603 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 17.1 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.607 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.808 ' HD2' HD21 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.671 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.681 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.527 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.482 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.614 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.415 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 -105.03 118.55 36.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -137.87 114.18 9.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 121.95 -0.469 . . . . 15.0 110.766 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.42 77.19 4.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.1 2.533 . . . . 15.0 111.792 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.657 HD13 ' H3 ' ' A' ' 279' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.263 0.078 . . . . 15.0 111.027 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.98 -61.98 0.58 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.775 -1.202 . . . . 15.0 114.237 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -89.67 150.08 5.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.68 2.253 . . . . 15.0 114.0 -168.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.656 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp -116.63 116.86 38.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.341 -0.845 . . . . 15.0 109.802 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.752 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.698 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.429 ' H ' HG12 ' A' ' 288' ' ' VAL . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 1.0 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.573 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.573 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 1.0 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.752 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.735 HG22 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.649 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.698 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 29.2 m170 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.453 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.766 HG23 HE22 ' A' ' 307' ' ' GLN . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.766 HE22 HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.653 ' OD2' HD11 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.656 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.653 HD11 ' OD2' ' A' ' 310' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.651 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.651 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.553 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.735 ' O ' HG22 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.608 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.503 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.602 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 -115.51 140.93 48.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -141.16 119.58 8.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.907 0.384 . . . . 15.0 110.403 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -92.51 65.81 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.209 2.606 . . . . 15.0 112.165 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.221 -0.445 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.641 ' H2 ' HD12 ' A' ' 279' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.651 0.263 . . . . 15.0 110.4 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 174.93 -171.21 44.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.589 -0.815 . . . . 15.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.8 135.93 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.067 2.512 . . . . 15.0 112.513 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.767 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp -110.78 117.55 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.253 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.735 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.667 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.661 HG22 HD12 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.942 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.661 HD12 HG22 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.942 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.735 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.741 HG22 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.557 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.667 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 34.9 m170 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.557 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.469 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.645 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.767 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.416 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.421 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.564 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.562 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.741 ' O ' HG22 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.884 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.506 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 -118.97 99.94 7.05 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 18.7 t70 -142.26 120.11 7.41 Favored Pre-proline 0 C--O 1.234 0.258 0 O-C-N 121.888 -0.507 . . . . 15.0 110.35 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 6.0 Cg_exo -79.45 89.31 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.125 2.55 . . . . 15.0 111.869 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.405 -0.361 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.31 -0.256 . . . . 15.0 110.31 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.71 -70.66 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 C-N-CA 119.734 -1.222 . . . . 15.0 113.876 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -89.85 148.38 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.749 2.299 . . . . 15.0 113.848 -170.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp -108.13 117.47 54.87 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 15.0 109.39 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.74 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.562 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.644 HG13 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.755 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.755 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.74 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 228' ' ' LEU . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.44 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.634 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 28.6 m170 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.44 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.562 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.476 ' O ' HG22 ' A' ' 306' ' ' THR . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.634 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.463 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.687 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.535 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -114.62 128.39 56.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -150.14 119.88 3.8 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 120.166 -0.614 . . . . 15.0 110.569 -177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.01 -55.56 3.11 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.974 2.449 . . . . 15.0 111.936 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.084 -0.507 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.729 -0.471 . . . . 15.0 109.729 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 136.03 -158.11 23.74 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.76 -0.733 . . . . 15.0 112.419 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -93.54 148.75 2.31 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.877 3.052 . . . . 15.0 113.811 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.716 HD21 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp -102.47 113.11 66.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.727 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.699 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.619 HG11 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.996 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.517 HD13 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.996 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.727 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.476 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.699 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.437 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.476 HG21 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.511 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.716 ' HD2' HD21 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.511 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.613 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.494 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.595 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.556 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 -95.36 131.1 41.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 28.6 t70 -150.08 111.09 3.29 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.269 0.486 . . . . 15.0 110.833 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -78.68 83.74 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.137 2.558 . . . . 15.0 111.904 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.198 -0.455 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.799 0.296 . . . . 15.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.68 42.83 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.532 -0.842 . . . . 15.0 113.166 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -89.99 147.16 4.65 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.596 2.864 . . . . 15.0 113.614 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp -104.73 108.08 59.97 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.681 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.694 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.424 HG13 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' B' ' 230' ' ' PRO . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.477 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.674 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.681 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.435 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.694 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 20.3 m170 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.435 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.58 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.524 HE21 HG22 ' A' ' 309' ' ' THR . 40.2 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' THR . . . . . 0.524 HG22 HE21 ' A' ' 307' ' ' GLN . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.521 ' HD2' HD21 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.557 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.578 ' O ' HG23 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.692 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.498 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.683 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.43 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -120.98 131.81 54.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.02 103.43 3.18 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.64 93.26 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.878 2.385 . . . . 15.0 112.465 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 312' ' ' ARG . 2.1 pt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.247 -0.279 . . . . 15.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.25 -96.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.286 -0.959 . . . . 15.0 113.393 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -89.79 144.19 4.4 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.962 2.441 . . . . 15.0 113.972 -172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.6 tp -114.07 119.04 41.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.713 -0.676 . . . . 15.0 109.34 174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.485 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.748 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.685 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.478 HG23 HD12 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 1.018 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.561 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 1.018 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.748 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.706 HG23 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.685 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.562 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.561 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.871 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.871 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.496 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.643 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.706 ' O ' HG23 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.685 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.871 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.673 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 -108.63 122.64 47.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 24.4 t70 -150.03 128.44 5.97 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 118.285 0.493 . . . . 15.0 110.611 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 35.9 Cg_exo -57.79 -73.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.383 2.722 . . . . 15.0 112.357 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.411 -0.359 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.627 HD21 ' H3 ' ' A' ' 279' ' ' LEU . 2.3 pt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.815 -0.439 . . . . 15.0 109.815 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.669 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -161.29 97.1 0.15 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.185 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.84 114.45 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.915 2.41 . . . . 15.0 112.215 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.38 116.1 65.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.329 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.779 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.759 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.642 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.627 HD13 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.642 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.779 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.791 HG22 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.759 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 9.3 m170 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.493 HD21 HG22 ' A' ' 305' ' ' THR . 7.9 t30 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.493 HG22 HD21 ' A' ' 303' ' ' ASN . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.619 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.496 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.669 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.614 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.614 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.575 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.54 ' HA ' HG11 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.791 ' O ' HG22 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.622 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.93 99.99 7.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.8 t70 -118.1 115.31 36.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.552 -0.718 . . . . 15.0 110.869 -175.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.7 Cg_exo -77.66 83.65 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.072 2.515 . . . . 15.0 111.431 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.169 -0.468 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.655 ' H3 ' HD22 ' A' ' 279' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.174 -0.676 . . . . 15.0 109.174 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.938 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -113.77 105.89 1.67 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.993 -1.099 . . . . 15.0 114.144 -172.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.14 114.03 0.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.049 2.5 . . . . 15.0 110.664 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp -98.16 115.69 65.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.702 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.973 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.973 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.758 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.533 ' OD2' HG21 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.702 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.533 HG21 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.88 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.436 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.66 ' HB3' HD23 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.938 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.457 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.65 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.472 ' H ' HG13 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.56 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.672 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.45 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 -112.17 132.23 55.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 33.7 t70 -149.57 111.38 3.41 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 15.0 111.128 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.9 Cg_endo -87.47 80.29 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.629 2.886 . . . . 15.0 111.854 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.202 -0.454 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.708 ' H2 ' HD23 ' A' ' 279' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.801 -0.444 . . . . 15.0 109.801 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 281' ' ' PRO . . . 160.81 -38.56 0.43 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.635 -0.793 . . . . 15.0 114.686 -172.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 280' ' ' GLY . 82.1 Cg_endo -89.78 148.11 4.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 CA-C-N 120.316 2.058 . . . . 15.0 113.596 -172.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp -112.74 116.33 47.93 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.136 -0.938 . . . . 15.0 109.849 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 286' ' ' TRP . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.754 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.711 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.914 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.914 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.754 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.606 HG22 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.711 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.2 m170 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.501 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.719 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.9 mm-40 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.406 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.57 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.57 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.558 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.558 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.719 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.633 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.606 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.715 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 -128.16 124.16 36.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.1 99.88 3.24 Favored Pre-proline 0 N--CA 1.451 -0.402 0 O-C-N 121.766 -0.584 . . . . 15.0 110.023 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.4 86.47 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.287 2.658 . . . . 15.0 112.145 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.261 -0.427 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.8 tp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.4 0.143 . . . . 15.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 135.34 -60.04 0.65 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.934 -1.127 . . . . 15.0 114.678 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -89.74 138.07 2.97 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.354 2.036 . . . . 15.0 114.253 -168.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 54.2 tp -108.93 115.64 56.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 114.985 -1.007 . . . . 15.0 109.693 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.762 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.763 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 288' ' ' VAL . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.871 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.871 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.762 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.763 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.3 m170 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.744 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.559 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.494 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.744 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.632 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.758 ' O ' HG23 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.664 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.8 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -132.35 99.93 4.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 30.5 t70 -114.98 117.44 41.73 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.928 -0.482 . . . . 15.0 111.255 -172.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 9.9 Cg_endo -88.83 84.92 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.547 2.831 . . . . 15.0 112.205 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 111.695 0.257 . . . . 15.0 111.695 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.455 ' CA ' ' HA ' ' A' ' 312' ' ' ARG . . . -93.06 -178.6 40.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.673 -0.775 . . . . 15.0 112.543 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -89.77 134.3 2.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.07 2.513 . . . . 15.0 112.923 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.529 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp -110.72 122.24 38.81 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.245 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.746 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.711 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.832 ' HB ' HD13 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.906 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.832 HD13 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.906 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.746 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.64 ' CG1' ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.711 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 31.5 m170 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.529 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.515 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.64 ' HA ' ' CG1' ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG22 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.456 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.441 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 -101.19 99.91 10.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -136.36 122.53 13.75 Favored Pre-proline 0 C--O 1.235 0.323 0 O-C-N 121.679 -0.638 . . . . 15.0 110.909 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.7 -63.95 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.322 2.681 . . . . 15.0 112.585 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.474 -0.33 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 311' ' ' PRO . 62.2 tp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.457 -0.201 . . . . 15.0 110.457 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 146.44 -74.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.049 -1.072 . . . . 15.0 113.762 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -89.73 141.57 3.85 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.724 2.283 . . . . 15.0 113.996 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp -99.83 121.87 52.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.591 -0.731 . . . . 15.0 109.313 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.74 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.664 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.608 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.783 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 296' ' ' ILE . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.783 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.74 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.664 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 37.1 m170 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.736 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . 0.453 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.416 ' O ' ' HB3' ' A' ' 279' ' ' LEU . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . 0.403 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.671 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.671 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.736 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.664 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.493 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.767 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 -136.61 99.96 4.21 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.13 117.08 3.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 121.447 -0.783 . . . . 15.0 110.918 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.06 66.5 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.699 2.266 . . . . 15.0 111.947 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.527 ' H1 ' HD13 ' A' ' 279' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.889 0.376 . . . . 15.0 110.096 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -85.23 175.86 49.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.859 -0.686 . . . . 15.0 111.88 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -89.74 123.12 1.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.804 2.336 . . . . 15.0 112.905 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.99 116.14 65.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.184 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.428 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.544 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.749 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLU . . . . . 0.751 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.976 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.976 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PHE . . . . . 0.749 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.751 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.544 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 1.5 p30 -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.404 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . 0.574 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.404 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.609 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' TYR . . . . . 0.654 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . 0.487 ' HA ' ' HE2' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' PRO . . . . . 0.504 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLU . . . . . 0.484 ' CD ' HH21 ' A' ' 289' ' ' ARG . 20.0 pt-20 -124.42 110.65 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -149.92 111.86 3.34 Favored Pre-proline 0 N--CA 1.457 -0.121 0 O-C-N 121.61 -0.681 . . . . 15.0 110.197 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.61 75.25 5.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.594 2.196 . . . . 15.0 112.392 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.159 -0.473 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.454 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.807 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.807 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.573 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 18.6 m-70 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.847 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.847 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.865 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.573 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.573 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.49 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.934 HG23 HD11 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.916 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.934 HD11 HG23 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.916 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.845 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.505 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 14.4 m-70 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.556 ' HB2' HG12 ' A' ' 296' ' ' ILE . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.641 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.535 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 304' ' ' ARG . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.505 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.524 -0.547 . . . . 15.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.446 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.696 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.551 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.576 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.696 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.565 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 19.7 m-70 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASN . . . . . 0.446 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.633 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 79.2 mm-40 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.565 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.551 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.554 ' H ' ' HE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.719 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.567 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.863 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.863 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.719 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.714 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 10.1 m-70 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.667 ' HA ' HG12 ' A' ' 299' ' ' VAL . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.714 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.467 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.574 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.492 -0.558 . . . . 15.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.706 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.608 ' HB2' HG22 ' A' ' 299' ' ' VAL . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' THR . . . . . 0.441 ' HA ' HH12 ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.875 HD11 HG23 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.629 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.8 m-70 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.499 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.439 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.51 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.552 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 299' ' ' VAL . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.629 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.446 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.718 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.485 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.713 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.594 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.476 HD11 ' HB ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.713 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.718 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.655 ' HB3' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.578 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.9 m-70 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.0 mm-40 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' B' ' 224' ' ' PRO . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.519 ' HD3' HD22 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.565 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.594 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.611 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.553 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.789 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.456 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.578 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.595 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.823 HD22 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.848 0.356 . . . . 15.0 110.102 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.674 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.599 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.989 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.626 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.989 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.611 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.617 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 13.2 m-70 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.611 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 65.5 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.626 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.823 ' HD2' HD22 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.7 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.566 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.702 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.617 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.63 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.453 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.501 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.599 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.757 ' CB ' ' HG2' ' A' ' 307' ' ' GLN . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.745 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.517 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.6 m-70 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 304' ' ' ARG . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.659 HG22 ' OD2' ' A' ' 300' ' ' ASP . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.757 ' HG2' ' CB ' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.487 ' OD2' HD13 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.686 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.654 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.541 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.745 ' O ' HG21 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.517 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.674 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.253 -0.277 . . . . 15.0 110.253 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.709 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.964 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.964 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.709 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.748 HG21 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.51 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 20.5 m-70 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.568 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.477 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.415 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.459 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.459 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.788 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.686 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.748 ' O ' HG21 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.51 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.904 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.524 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.708 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.654 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.774 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.774 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.708 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' B' ' 227' ' ' TYR . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.553 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.6 m-70 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.58 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.573 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 313' ' ' LEU . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.698 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.531 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.553 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.694 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.557 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp . . . . . 0 C--O 1.233 0.219 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.487 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 1.007 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 1.007 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.571 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 18.4 m-70 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.485 HG22 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 5.7 tp60 -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.524 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.524 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.695 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.528 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.571 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.552 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.581 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.645 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.48 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.69 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.645 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.606 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.1 m-70 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.437 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 298' ' ' PHE . 6.9 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.528 ' HD2' HD22 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.589 ' O ' HG21 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.741 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.606 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 312' ' ' ARG . 24.6 tp . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.487 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.7 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.474 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.557 HG23 HD11 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.7 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.494 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 11.0 m-70 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.453 ' HD3' HD13 ' A' ' 282' ' ' LEU . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.521 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 304' ' ' ARG . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.494 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.847 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.72 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.721 0.296 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.751 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.55 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.664 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.664 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.751 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.797 HG21 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.574 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.7 m-70 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.622 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.502 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.696 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.797 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.574 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.736 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.674 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.994 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.994 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.736 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.711 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 13.0 m-70 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.543 HG22 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.7 mm-40 -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.674 ' HB3' HD21 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 312' ' ' ARG . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.74 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.441 ' H ' HG11 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.711 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.674 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.448 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.849 -0.426 . . . . 15.0 109.849 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 284' ' ' PRO . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.723 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.929 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.929 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.723 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.62 HG21 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.557 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 14.4 m-70 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.583 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.546 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.753 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.582 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.557 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.616 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.724 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' A' ' 312' ' ' ARG . 54.2 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.559 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.887 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.887 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.765 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.559 ' NE2' ' HG2' ' A' ' 287' ' ' GLU . 13.0 m-70 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.771 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.8 mm-40 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.517 ' HD2' HD13 ' A' ' 282' ' ' LEU . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.771 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.506 ' HD2' ' HD1' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.765 ' O ' HG21 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.456 ' HB3' ' NE2' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.831 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.245 -0.28 . . . . 15.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.705 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.507 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.823 ' HB ' HD11 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.921 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.823 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.921 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.705 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.585 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 21.8 m-70 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.407 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.617 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.691 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.585 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.473 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.522 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.313 -0.625 . . . . 15.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.69 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.469 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.79 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.79 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 227' ' ' TYR . 16.2 m-70 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . 0.454 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.799 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.402 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.672 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.672 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.766 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.641 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.43 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.716 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.184 -0.302 . . . . 15.0 110.184 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLU . . . . . 0.547 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.991 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . 0.404 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.991 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' PHE . . . . . 0.717 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 301' ' ' HIS . . . . . 0.625 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 15.0 m-70 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASN . . . . . 0.597 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 224' ' ' PRO . . . . . 0.592 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' TYR . . . . . 0.721 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' PRO . . . . . 0.625 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 20.0 pt-20 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.603 0.223 . . . . 15.0 111.603 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -165.34 -95.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.535 -1.317 . . . . 15.0 114.429 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -89.8 150.03 4.98 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.506 2.804 . . . . 15.0 114.825 -166.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp -108.51 118.02 53.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.507 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.454 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.807 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.807 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.573 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 18.6 m-70 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.847 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.847 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.865 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.573 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.573 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 -96.63 99.91 11.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 17.9 t70 -138.72 114.28 8.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 O-C-N 121.976 -0.452 . . . . 15.0 110.482 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.8 Cg_exo -78.41 84.58 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.905 2.403 . . . . 15.0 111.469 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.104 -0.498 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.02 0.438 . . . . 15.0 110.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -127.67 -127.83 3.05 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.579 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 311' ' ' PRO . 22.3 Cg_endo -91.77 149.02 3.34 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.558 2.838 . . . . 15.0 113.879 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp -91.64 107.7 24.06 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 167.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.49 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.934 HG23 HD11 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.916 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.934 HD11 HG23 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.916 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.845 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.505 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 14.4 m-70 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.556 ' HB2' HG12 ' A' ' 296' ' ' ILE . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 281' ' ' PRO . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.641 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.535 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 304' ' ' ARG . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.505 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.94 126.63 51.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.3 t70 -134.18 114.3 12.63 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.695 -0.628 . . . . 15.0 110.943 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -75.19 89.8 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.177 2.585 . . . . 15.0 112.073 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.404 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.937 -0.394 . . . . 15.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 156.41 -141.14 7.71 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.676 -1.249 . . . . 15.0 113.731 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -89.91 150.04 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.811 3.007 . . . . 15.0 114.128 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp -121.14 111.45 33.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.661 -0.7 . . . . 15.0 109.524 171.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.446 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.696 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.551 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.576 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.696 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.565 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 19.7 m-70 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.446 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.633 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 79.2 mm-40 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.565 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.551 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.554 ' H ' ' HE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 -105.94 99.04 8.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 20.7 t70 -147.29 112.97 4.09 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 121.033 -1.042 . . . . 15.0 111.574 -169.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 3.4 Cg_exo -80.96 88.12 1.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.443 2.762 . . . . 15.0 111.658 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.168 -0.469 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 311' ' ' PRO . 7.1 mp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.458 0.171 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 141.05 -78.66 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.9 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -89.77 148.18 4.93 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.875 2.384 . . . . 15.0 114.023 -170.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp -113.83 113.31 47.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.56 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.719 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.567 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.863 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.863 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.719 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.714 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 10.1 m-70 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.661 ' HA ' HD13 ' A' ' 279' ' ' LEU . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.667 ' HA ' HG12 ' A' ' 299' ' ' VAL . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.714 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.467 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.574 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 -125.66 117.8 24.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.07 108.52 3.23 Favored Pre-proline 0 C--O 1.234 0.256 0 O-C-N 121.717 -0.615 . . . . 15.0 110.745 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -95.19 67.65 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.254 2.636 . . . . 15.0 112.282 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 111.86 0.318 . . . . 15.0 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 154.4 -57.7 0.4 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.062 -1.542 . . . . 15.0 115.353 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.68 139.74 3.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.113 1.876 . . . . 15.0 114.599 -166.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp -101.38 117.55 61.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.085 -0.962 . . . . 15.0 109.492 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.706 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.608 ' HB2' HG22 ' A' ' 299' ' ' VAL . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.441 ' HA ' HH12 ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.875 HD11 HG23 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.629 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.8 m-70 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.499 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.439 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.51 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.552 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.59 ' HA ' HG12 ' A' ' 299' ' ' VAL . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.629 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.446 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 -89.93 99.1 12.18 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 25.3 t70 -150.3 110.01 3.21 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 121.131 -0.98 . . . . 15.0 111.35 -169.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 9.4 Cg_endo -88.86 82.69 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.462 2.775 . . . . 15.0 112.027 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.435 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 279' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 110.12 -0.326 . . . . 15.0 110.12 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 162.48 -56.32 0.3 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.911 -1.138 . . . . 15.0 114.128 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -89.66 148.16 5.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.204 1.936 . . . . 15.0 113.889 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp -114.7 119.66 39.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.347 -0.842 . . . . 15.0 109.441 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.718 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.485 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.713 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.594 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.476 HD11 ' HB ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.713 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.718 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.655 ' HB3' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.578 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.9 m-70 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.0 mm-40 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' B' ' 224' ' ' PRO . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.519 ' HD3' HD22 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.565 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.594 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.611 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.553 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.789 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.456 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.578 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.595 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 -117.77 129.48 55.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.97 114.72 3.42 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 118.376 0.535 . . . . 15.0 110.069 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.76 -73.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.18 2.586 . . . . 15.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.478 -0.328 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.837 0.351 . . . . 15.0 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -166.02 171.36 41.1 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.195 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -89.92 146.16 4.61 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.205 2.603 . . . . 15.0 112.822 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.823 HD22 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp -130.14 102.66 17.2 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.102 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.674 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.599 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.989 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.626 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.989 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.611 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.617 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 13.2 m-70 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.611 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 65.5 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.626 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.823 ' HD2' HD22 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.7 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.566 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.702 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.617 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.63 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.453 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 -105.03 118.55 36.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -137.87 114.18 9.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 121.95 -0.469 . . . . 15.0 110.766 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.42 77.19 4.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.1 2.533 . . . . 15.0 111.792 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.263 0.078 . . . . 15.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.98 -61.98 0.58 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.775 -1.202 . . . . 15.0 114.237 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -89.67 150.08 5.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.68 2.253 . . . . 15.0 114.0 -168.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp -116.63 116.86 38.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.341 -0.845 . . . . 15.0 109.802 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.501 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.599 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.757 ' CB ' ' HG2' ' A' ' 307' ' ' GLN . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.745 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.517 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.6 m-70 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 304' ' ' ARG . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.659 HG22 ' OD2' ' A' ' 300' ' ' ASP . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.757 ' HG2' ' CB ' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.487 ' OD2' HD13 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.686 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.654 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.541 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.745 ' O ' HG21 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.517 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.674 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 -115.51 140.93 48.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 12.1 t70 -141.16 119.58 8.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.907 0.384 . . . . 15.0 110.403 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 68.7 Cg_endo -92.51 65.81 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.209 2.606 . . . . 15.0 112.165 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.221 -0.445 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.651 0.263 . . . . 15.0 110.4 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 174.93 -171.21 44.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.589 -0.815 . . . . 15.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.8 135.93 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.067 2.512 . . . . 15.0 112.513 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp -110.78 117.55 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.253 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.709 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.458 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.964 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.964 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.709 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.748 HG21 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.51 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 20.5 m-70 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.568 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.477 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.415 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.459 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.459 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.788 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.686 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.748 ' O ' HG21 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.51 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.904 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.524 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 -118.97 99.94 7.05 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 18.7 t70 -142.26 120.11 7.41 Favored Pre-proline 0 C--O 1.234 0.258 0 O-C-N 121.888 -0.507 . . . . 15.0 110.35 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 6.0 Cg_exo -79.45 89.31 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.125 2.55 . . . . 15.0 111.869 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.405 -0.361 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.31 -0.256 . . . . 15.0 110.31 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.71 -70.66 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 C-N-CA 119.734 -1.222 . . . . 15.0 113.876 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -89.85 148.38 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.749 2.299 . . . . 15.0 113.848 -170.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp -108.13 117.47 54.87 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 15.0 109.39 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.708 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.654 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.774 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.774 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.708 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' B' ' 227' ' ' TYR . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.553 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.6 m-70 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.58 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.573 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 313' ' ' LEU . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.698 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.531 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.553 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.694 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.557 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -114.62 128.39 56.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -150.14 119.88 3.8 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 120.166 -0.614 . . . . 15.0 110.569 -177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.01 -55.56 3.11 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.974 2.449 . . . . 15.0 111.936 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.084 -0.507 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.729 -0.471 . . . . 15.0 109.729 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 136.03 -158.11 23.74 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.76 -0.733 . . . . 15.0 112.419 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -93.54 148.75 2.31 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.877 3.052 . . . . 15.0 113.811 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp -102.47 113.11 66.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.487 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 1.007 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 1.007 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.571 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 18.4 m-70 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.485 HG22 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 5.7 tp60 -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.524 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.524 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.695 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.528 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.571 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.552 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.581 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 -95.36 131.1 41.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 28.6 t70 -150.08 111.09 3.29 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.269 0.486 . . . . 15.0 110.833 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -78.68 83.74 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.137 2.558 . . . . 15.0 111.904 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.198 -0.455 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.799 0.296 . . . . 15.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.68 42.83 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.532 -0.842 . . . . 15.0 113.166 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -89.99 147.16 4.65 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.596 2.864 . . . . 15.0 113.614 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp -104.73 108.08 59.97 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.645 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.48 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.69 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.645 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.606 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 17.1 m-70 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.437 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 298' ' ' PHE . 6.9 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.528 ' HD2' HD22 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.589 ' O ' HG21 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.741 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.606 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -120.98 131.81 54.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.02 103.43 3.18 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.64 93.26 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.878 2.385 . . . . 15.0 112.465 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 312' ' ' ARG . 2.1 pt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.247 -0.279 . . . . 15.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.25 -96.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.286 -0.959 . . . . 15.0 113.393 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -89.79 144.19 4.4 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.962 2.441 . . . . 15.0 113.972 -172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 312' ' ' ARG . 24.6 tp -114.07 119.04 41.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.713 -0.676 . . . . 15.0 109.34 174.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.487 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.7 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.474 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.557 HG23 HD11 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.7 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.494 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 11.0 m-70 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.521 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 304' ' ' ARG . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.494 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.847 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.72 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 -108.63 122.64 47.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.452 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 24.4 t70 -150.03 128.44 5.97 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 118.285 0.493 . . . . 15.0 110.611 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 35.9 Cg_exo -57.79 -73.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.383 2.722 . . . . 15.0 112.357 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.411 -0.359 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.815 -0.439 . . . . 15.0 109.815 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.707 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -161.29 97.1 0.15 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.185 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.84 114.45 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.915 2.41 . . . . 15.0 112.215 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.38 116.1 65.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.329 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.751 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.55 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.664 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.664 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.751 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.797 HG21 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.574 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 12.7 m-70 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.622 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.502 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.707 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.696 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.797 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.574 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.93 99.99 7.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.8 t70 -118.1 115.31 36.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.552 -0.718 . . . . 15.0 110.869 -175.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.7 Cg_exo -77.66 83.65 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.072 2.515 . . . . 15.0 111.431 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.169 -0.468 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 279' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.174 -0.676 . . . . 15.0 109.174 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.964 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -113.77 105.89 1.67 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.993 -1.099 . . . . 15.0 114.144 -172.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.14 114.03 0.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.049 2.5 . . . . 15.0 110.664 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp -98.16 115.69 65.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.736 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.674 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.994 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.994 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.736 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.711 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 13.0 m-70 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.543 HG22 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.537 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.7 mm-40 -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.674 ' HB3' HD21 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.964 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.74 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.441 ' H ' HG11 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.711 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.674 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.448 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 -112.17 132.23 55.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 33.7 t70 -149.57 111.38 3.41 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 15.0 111.128 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.9 Cg_endo -87.47 80.29 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.629 2.886 . . . . 15.0 111.854 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.202 -0.454 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.801 -0.444 . . . . 15.0 109.801 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 281' ' ' PRO . . . 160.81 -38.56 0.43 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.635 -0.793 . . . . 15.0 114.686 -172.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 280' ' ' GLY . 82.1 Cg_endo -89.78 148.11 4.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 CA-C-N 120.316 2.058 . . . . 15.0 113.596 -172.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp -112.74 116.33 47.93 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.136 -0.938 . . . . 15.0 109.849 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 284' ' ' PRO . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.723 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.616 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.929 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.929 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.723 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.62 HG21 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.557 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 14.4 m-70 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.583 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.546 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.753 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.582 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.557 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.616 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.724 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 -128.16 124.16 36.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.1 99.88 3.24 Favored Pre-proline 0 N--CA 1.451 -0.402 0 O-C-N 121.766 -0.584 . . . . 15.0 110.023 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.4 86.47 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.287 2.658 . . . . 15.0 112.145 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.261 -0.427 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.8 tp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.4 0.143 . . . . 15.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 135.34 -60.04 0.65 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.934 -1.127 . . . . 15.0 114.678 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -89.74 138.07 2.97 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.354 2.036 . . . . 15.0 114.253 -168.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' A' ' 312' ' ' ARG . 54.2 tp -108.93 115.64 56.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 114.985 -1.007 . . . . 15.0 109.693 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.559 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.887 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.887 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.765 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.559 ' NE2' ' HG2' ' A' ' 287' ' ' GLU . 13.0 m-70 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.771 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.8 mm-40 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.517 ' HD2' HD13 ' A' ' 282' ' ' LEU . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.771 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.506 ' HD2' ' HD1' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.765 ' O ' HG21 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.456 ' HB3' ' NE2' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.831 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -132.35 99.93 4.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 30.5 t70 -114.98 117.44 41.73 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.928 -0.482 . . . . 15.0 111.255 -172.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 9.9 Cg_endo -88.83 84.92 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.547 2.831 . . . . 15.0 112.205 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 111.695 0.257 . . . . 15.0 111.695 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 312' ' ' ARG . . . -93.06 -178.6 40.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.673 -0.775 . . . . 15.0 112.543 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -89.77 134.3 2.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.07 2.513 . . . . 15.0 112.923 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp -110.72 122.24 38.81 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.245 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.705 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.507 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.823 ' HB ' HD11 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.921 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.823 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.921 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.705 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.585 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 21.8 m-70 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.407 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.617 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.691 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.585 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.473 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.522 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 -101.19 99.91 10.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 18.7 t70 -136.36 122.53 13.75 Favored Pre-proline 0 C--O 1.235 0.323 0 O-C-N 121.679 -0.638 . . . . 15.0 110.909 -176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 51.5 Cg_exo -54.7 -63.95 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.322 2.681 . . . . 15.0 112.585 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.474 -0.33 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 311' ' ' PRO . 62.2 tp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.457 -0.201 . . . . 15.0 110.457 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 146.44 -74.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.049 -1.072 . . . . 15.0 113.762 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -89.73 141.57 3.85 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.724 2.283 . . . . 15.0 113.996 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp -99.83 121.87 52.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.591 -0.731 . . . . 15.0 109.313 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.69 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.469 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.79 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.79 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.587 ' HA ' ' CE2' ' B' ' 227' ' ' TYR . 16.2 m-70 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . 0.454 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 279' ' ' LEU . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.799 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.402 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.672 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.672 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.766 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.651 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.641 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.43 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.716 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 -136.61 99.96 4.21 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.13 117.08 3.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 121.447 -0.783 . . . . 15.0 110.918 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.06 66.5 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.699 2.266 . . . . 15.0 111.947 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.889 0.376 . . . . 15.0 110.096 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -85.23 175.86 49.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.859 -0.686 . . . . 15.0 111.88 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -89.74 123.12 1.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.804 2.336 . . . . 15.0 112.905 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.99 116.14 65.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.184 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLU . . . . . 0.547 ' HG2' ' NE2' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.991 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . 0.404 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.991 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PHE . . . . . 0.717 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.625 ' HE1' ' HA ' ' B' ' 229' ' ' PRO . 15.0 m-70 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASN . . . . . 0.597 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' PRO . . . . . 0.592 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' TYR . . . . . 0.721 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' PRO . . . . . 0.625 ' HA ' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 20.0 pt-20 -124.42 110.65 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -149.92 111.86 3.34 Favored Pre-proline 0 N--CA 1.457 -0.121 0 O-C-N 121.61 -0.681 . . . . 15.0 110.197 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.61 75.25 5.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.594 2.196 . . . . 15.0 112.392 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.159 -0.473 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 CA--C 1.529 0.166 0 N-CA-C 109.507 -0.553 . . . . 15.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.65 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.544 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.807 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.807 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.669 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 27.1 m170 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.847 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.847 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.865 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.573 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.688 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.934 HG23 HD11 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.916 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.934 HD11 HG23 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.916 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.845 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.688 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 21.3 m170 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.556 ' HB2' HG12 ' A' ' 296' ' ' ILE . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.641 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.535 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.571 ' CD1' ' HD2' ' A' ' 301' ' ' HIS . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.604 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.524 -0.547 . . . . 15.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.446 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.696 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.66 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.576 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.696 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.66 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.3 m170 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.446 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.633 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.2 mm100 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.487 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.551 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.554 ' H ' ' HE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp . . . . . 0 C--O 1.233 0.211 0 N-CA-C 109.56 -0.533 . . . . 15.0 109.56 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.719 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.863 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.863 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.719 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 17.7 m170 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.667 ' HA ' HG12 ' A' ' 299' ' ' VAL . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.478 ' HA ' ' NE2' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.467 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.574 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 109.492 -0.558 . . . . 15.0 109.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.706 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.746 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.608 ' HB2' HG22 ' A' ' 299' ' ' VAL . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . 0.441 ' HA ' HH12 ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.875 HD11 HG23 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.746 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.499 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.439 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.51 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.552 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.724 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.446 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 . . . . . 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.441 -0.577 . . . . 15.0 109.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.718 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.621 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.713 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.594 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.476 HD11 ' HB ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.713 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.718 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.655 ' HB3' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.676 ' HD2' ' CD1' ' B' ' 227' ' ' TYR . 7.8 m170 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.3 mm100 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' B' ' 224' ' ' PRO . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.519 ' HD3' HD22 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.565 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.594 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.611 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.553 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.789 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.456 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.595 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.823 HD22 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.848 0.356 . . . . 15.0 110.102 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.674 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.599 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.989 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.626 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.989 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.611 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.686 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 50.6 m170 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.611 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 17.1 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.626 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.823 ' HD2' HD22 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.7 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.566 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.702 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.63 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.453 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.694 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.599 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.757 ' CB ' ' HG2' ' A' ' 307' ' ' GLN . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.745 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.694 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 29.2 m170 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 304' ' ' ARG . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.778 HG23 HE22 ' A' ' 307' ' ' GLN . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.778 HE22 HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.487 ' OD2' HD13 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.686 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.654 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.745 ' O ' HG21 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.6 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.674 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.253 -0.277 . . . . 15.0 110.253 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.709 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.669 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.964 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.964 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.709 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.748 HG21 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 34.9 m170 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.568 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.477 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.415 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.459 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.459 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.788 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.686 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.748 ' O ' HG21 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.904 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.524 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 109.39 -0.596 . . . . 15.0 109.39 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.708 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.654 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.774 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.774 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.708 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' B' ' 227' ' ' TYR . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.641 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 28.6 m170 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.58 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.573 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 313' ' ' LEU . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.698 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.531 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.694 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.557 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp . . . . . 0 C--O 1.233 0.219 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 1.007 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 1.007 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.485 HG22 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.524 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.524 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.695 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.528 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.552 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.581 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp . . . . . 0 N--CA 1.456 -0.146 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.645 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.686 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.69 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.645 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.698 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 20.3 m170 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.437 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.574 HE21 HG23 ' A' ' 309' ' ' THR . 40.2 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . 0.574 HG23 HE21 ' A' ' 307' ' ' GLN . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.528 ' HD2' HD22 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.589 ' O ' HG21 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.741 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.482 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 . . . . . 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 312' ' ' ARG . 24.6 tp . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.487 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.7 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.674 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.557 HG23 HD11 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.7 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' B' ' 229' ' ' PRO . 7.9 m170 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.453 ' HD3' HD13 ' A' ' 282' ' ' LEU . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.521 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.661 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.847 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.72 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.721 0.296 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.751 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.748 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.664 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.664 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.751 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.797 HG21 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.748 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 9.3 m170 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.542 HD22 HG23 ' A' ' 305' ' ' THR . 7.9 t30 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 303' ' ' ASN . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.622 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.502 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.696 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.797 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.618 ' HB3' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.736 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.702 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.994 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.994 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.736 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.702 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.543 HG22 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.892 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.674 ' HB3' HD21 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 312' ' ' ARG . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.74 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.441 ' H ' HG11 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.461 ' HA ' ' NE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.674 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.448 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 . . . . . 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.849 -0.426 . . . . 15.0 109.849 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 284' ' ' PRO . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.723 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.709 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.929 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.929 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.723 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.62 HG21 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.709 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.2 m170 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.404 ' HB ' HE21 ' A' ' 307' ' ' GLN . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.9 mm-40 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.583 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.546 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.753 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.44 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.616 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.724 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 . . . . . 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' A' ' 312' ' ' ARG . 54.2 tp . . . . . 0 C--O 1.233 0.234 0 N-CA-C 109.693 -0.484 . . . . 15.0 109.693 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.759 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.887 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.887 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.765 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.759 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.3 m170 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.771 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.517 ' HD2' HD13 ' A' ' 282' ' ' LEU . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.771 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.645 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.765 ' O ' HG21 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.656 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.831 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.245 -0.28 . . . . 15.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.705 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.707 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.823 ' HB ' HD11 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.921 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.823 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.921 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.705 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.707 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 31.5 m170 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.407 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.617 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.691 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.473 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.522 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 109.313 -0.625 . . . . 15.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.69 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.66 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.79 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.79 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.671 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 37.1 m170 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . 0.454 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.799 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.402 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.672 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.672 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.766 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.671 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.641 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.475 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.716 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.184 -0.302 . . . . 15.0 110.184 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.55 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLU . . . . . 0.752 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.991 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . 0.404 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.991 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' PHE . . . . . 0.717 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' HIS . . . . . 0.752 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASN . . . . . 0.55 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 1.5 p30 -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASN . . . . . 0.597 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' PRO . . . . . 0.592 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' TYR . . . . . 0.721 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 20.0 pt-20 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 111.603 0.223 . . . . 15.0 111.603 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -165.34 -95.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 119.535 -1.317 . . . . 15.0 114.429 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -89.8 150.03 4.98 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 123.506 2.804 . . . . 15.0 114.825 -166.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 56.7 tp -108.51 118.02 53.04 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.284 -0.871 . . . . 15.0 109.507 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.35 137.67 37.22 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.937 2.425 . . . . 15.0 112.793 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.54 133.07 40.81 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.858 2.372 . . . . 15.0 111.952 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.53 -5.39 35.27 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.807 -0.711 . . . . 15.0 111.406 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.71 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 7.1 m95 -89.79 113.47 25.03 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.111 -0.544 . . . . 15.0 111.248 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.65 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -97.06 126.52 42.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 109.369 -0.604 . . . . 15.0 109.369 174.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.544 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 35.1 m -89.93 101.74 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.741 0.781 . . . . 15.0 110.226 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.807 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.3 OUTLIER -93.08 103.94 16.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.765 -1.198 . . . . 15.0 107.765 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 32.1 p -104.53 148.76 26.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.351 -0.84 . . . . 15.0 111.269 -171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.5 p -131.61 149.3 52.55 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.33 -0.396 . . . . 15.0 110.294 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.83 -14.96 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.337 -0.847 . . . . 15.0 112.395 -169.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.576 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 12.6 m -59.49 -14.87 14.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.824 0.345 . . . . 15.0 111.105 175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.37 30.11 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.258 -0.737 . . . . 15.0 111.258 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 34.3 ptt180 -118.71 114.68 23.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.32 0.581 . . . . 15.0 110.036 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.64 141.32 14.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.588 -1.264 . . . . 15.0 107.588 172.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.807 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 6.4 p90 -150.36 133.59 16.29 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.337 -0.986 . . . . 15.0 108.337 -172.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.71 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 2.5 m-85 -90.01 136.06 33.27 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 114.997 1.48 . . . . 15.0 114.997 -164.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.0 m -136.95 89.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-N 112.019 -2.355 . . . . 15.0 107.688 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.73 122.84 33.21 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.466 -0.939 . . . . 15.0 108.466 -177.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.669 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 27.1 m170 -83.99 -12.96 54.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.647 -0.706 . . . . 15.0 110.954 -172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.45 -61.09 1.82 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.011 0.434 . . . . 15.0 110.635 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.69 -14.88 36.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.263 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 39.4 ttp180 65.76 75.24 0.35 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.632 -0.713 . . . . 15.0 109.969 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.92 150.04 44.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.682 -175.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 36.9 p -129.74 130.85 45.95 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.742 0.306 . . . . 15.0 111.479 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.15 145.39 26.27 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 111.656 0.243 . . . . 15.0 111.656 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' B' ' 222' ' ' THR . 8.7 m-85 -91.04 -15.08 30.16 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.234 0.457 . . . . 15.0 112.234 176.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.2 m -82.4 111.87 18.83 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.37 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.521 ' HB3' HD13 ' A' ' 313' ' ' LEU . 10.3 t70 -92.4 121.11 67.02 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.897 0.38 . . . . 15.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.52 -14.63 30.73 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.478 2.786 . . . . 15.0 113.602 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -73.7 -24.67 59.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.067 -0.345 . . . . 15.0 110.067 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 310' ' ' ASP . 6.3 mp . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.319 -0.848 . . . . 15.0 109.836 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.564 -0.532 . . . . 15.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.847 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 17.3 p -71.58 -179.81 0.82 Allowed Pre-proline 0 C--O 1.218 -0.599 0 C-N-CA 123.139 0.575 . . . . 15.0 111.173 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.847 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 21.9 Cg_endo -62.05 149.0 92.05 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.973 1.782 . . . . 15.0 112.055 173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 36.3 Cg_endo -71.24 135.95 28.08 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.791 1.661 . . . . 15.0 113.614 -174.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 50.6 Cg_exo -57.68 -179.82 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.427 0 C-N-CA 124.245 3.297 . . . . 15.0 113.497 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.81 170.17 10.06 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.219 -0.66 . . . . 15.0 109.219 169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.865 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -91.76 135.94 33.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.935 0.874 . . . . 15.0 111.845 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 299' ' ' VAL . 81.7 mt -130.43 160.95 63.5 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.263 -1.335 . . . . 15.0 109.537 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -87.98 142.18 5.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 120.964 1.109 . . . . 15.0 109.271 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.492 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 37.4 Cg_endo -89.74 143.86 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 121.67 1.58 . . . . 15.0 116.03 -145.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.573 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.5 pm0 -96.63 99.91 11.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.213 -1.358 . . . . 15.0 109.013 167.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 17.9 t70 -138.72 114.28 8.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 O-C-N 121.976 -0.452 . . . . 15.0 110.482 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.8 Cg_exo -78.41 84.58 1.99 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.905 2.403 . . . . 15.0 111.469 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.625 0 CA-C-N 116.104 -0.498 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.02 0.438 . . . . 15.0 110.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -127.67 -127.83 3.05 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.612 -0.804 . . . . 15.0 112.579 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 311' ' ' PRO . 22.3 Cg_endo -91.77 149.02 3.34 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 123.558 2.838 . . . . 15.0 113.879 -175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 33.5 tp -91.64 107.7 24.06 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 108.691 -0.855 . . . . 15.0 108.691 167.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.98 131.29 25.03 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.684 2.256 . . . . 15.0 112.738 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -56.27 121.42 9.98 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.594 2.196 . . . . 15.0 111.453 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.87 -15.38 12.48 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.626 -0.99 . . . . 15.0 110.626 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.758 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.89 110.94 21.86 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.978 -0.611 . . . . 15.0 110.211 175.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.688 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 3.2 mp0 -90.54 112.11 23.67 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.208 -1.034 . . . . 15.0 108.208 170.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.934 HG23 HD11 ' A' ' 296' ' ' ILE . 0.1 OUTLIER -89.85 109.87 21.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.644 -0.707 . . . . 15.0 109.634 -177.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.916 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -100.06 104.64 16.22 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.954 -1.128 . . . . 15.0 107.954 -178.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 42.7 t -102.98 140.05 37.75 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.874 -1.057 . . . . 15.0 109.936 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 51.2 p -125.96 139.12 53.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.041 0.448 . . . . 15.0 111.578 -176.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.91 -16.36 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.133 -0.94 . . . . 15.0 112.605 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 6.0 p -61.06 -14.72 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.201 0.524 . . . . 15.0 111.021 175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.42 44.89 4.51 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.777 -0.647 . . . . 15.0 111.989 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -145.03 130.92 19.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.035 0.445 . . . . 15.0 110.501 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.934 HD11 HG23 ' A' ' 288' ' ' VAL . 9.7 tp -89.82 139.58 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.898 -0.778 . . . . 15.0 108.898 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.916 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.44 128.12 11.62 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.002 -1.11 . . . . 15.0 108.002 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.845 ' HB2' ' HB2' ' A' ' 307' ' ' GLN . 1.9 m-85 -95.64 140.24 30.75 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 114.981 1.474 . . . . 15.0 114.981 -168.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 23.6 m -128.65 90.38 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-N 112.156 -2.293 . . . . 15.0 108.669 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.81 118.26 29.27 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.237 -1.394 . . . . 15.0 107.237 174.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.688 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 21.3 m170 -83.26 -12.08 57.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.514 -168.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.7 -52.38 4.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.94 0.4 . . . . 15.0 110.952 -174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.48 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 13.7 m-80 -91.39 -14.78 30.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.454 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.566 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 27.9 ttp180 62.15 69.66 0.61 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.515 -0.766 . . . . 15.0 110.512 -175.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 40.0 p -123.84 147.55 47.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 15.0 110.977 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -119.16 118.47 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.789 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.845 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 15.9 mp0 -118.44 140.46 49.82 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.522 -173.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.408 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-85 -100.29 -14.64 18.34 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.885 -0.51 . . . . 15.0 111.472 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 11.9 t -91.77 145.1 24.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.636 -0.505 . . . . 15.0 109.636 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.556 ' HB2' HG12 ' A' ' 296' ' ' ILE . 12.2 t70 -123.46 136.04 26.74 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 15.0 111.337 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 281' ' ' PRO . 88.5 Cg_endo -80.14 -14.66 11.99 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.25 2.633 . . . . 15.0 113.776 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.641 HH11 HG21 ' A' ' 288' ' ' VAL . 70.2 mtp180 -74.31 -58.43 3.3 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.353 -0.217 . . . . 15.0 110.979 -175.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.301 -0.857 . . . . 15.0 111.038 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.349 -0.611 . . . . 15.0 109.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 10.7 p -59.91 157.28 31.09 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 122.476 0.31 . . . . 15.0 110.844 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.68 139.32 24.28 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.986 2.457 . . . . 15.0 113.346 -169.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.535 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 26.8 Cg_endo -62.36 136.25 58.46 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.774 2.316 . . . . 15.0 112.545 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 92.4 Cg_endo -77.99 179.98 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.195 2.597 . . . . 15.0 112.368 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.53 151.49 28.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.438 -0.346 . . . . 15.0 110.265 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.571 ' CD1' ' HD2' ' A' ' 301' ' ' HIS . 2.8 p90 -90.06 126.03 35.63 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.173 0.987 . . . . 15.0 110.936 -174.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.4 mp -130.28 161.06 62.61 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.268 -1.333 . . . . 15.0 108.171 175.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.604 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 6.6 Cg_exo -87.25 148.89 7.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.838 1.025 . . . . 15.0 111.729 -173.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 24.0 Cg_endo -97.52 159.21 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.278 2.652 . . . . 15.0 117.968 -137.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.94 126.63 51.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 112.97 -1.923 . . . . 15.0 107.885 167.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.3 t70 -134.18 114.3 12.63 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.695 -0.628 . . . . 15.0 110.943 -177.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -75.19 89.8 1.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.177 2.585 . . . . 15.0 112.073 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.312 -0.404 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 109.937 -0.394 . . . . 15.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 156.41 -141.14 7.71 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.676 -1.249 . . . . 15.0 113.731 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -89.91 150.04 4.88 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.811 3.007 . . . . 15.0 114.128 -172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.406 HD22 ' NH1' ' A' ' 312' ' ' ARG . 39.0 tp -121.14 111.45 33.84 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.661 -0.7 . . . . 15.0 109.524 171.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -67.06 130.11 22.13 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.72 2.28 . . . . 15.0 112.424 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.88 126.29 21.47 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.67 2.246 . . . . 15.0 111.668 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.446 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 113.72 -7.28 24.08 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.095 -0.802 . . . . 15.0 111.095 -174.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.696 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.7 m95 -89.72 103.34 16.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.211 -0.495 . . . . 15.0 110.046 177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.66 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -91.77 121.53 33.48 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.589 -0.893 . . . . 15.0 108.589 175.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.52 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.9 OUTLIER -89.96 112.7 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 122.148 0.975 . . . . 15.0 108.868 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.576 ' HB3' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.23 91.07 5.72 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.167 -1.42 . . . . 15.0 107.167 177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.4 p -96.34 106.74 19.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.229 -0.896 . . . . 15.0 111.574 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 22.7 p -92.64 150.14 20.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 111.938 0.347 . . . . 15.0 111.938 -173.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.5 p -62.51 -15.15 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 15.0 111.701 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 30.1 m -58.98 -14.54 9.6 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.218 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.7 4.67 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.008 -0.615 . . . . 15.0 111.808 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.609 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 12.6 ptt180 -149.91 125.85 10.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.134 0.492 . . . . 15.0 110.734 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.514 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.79 139.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.395 -1.335 . . . . 15.0 107.395 170.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 4.5 p90 -150.13 129.72 13.11 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.084 -1.451 . . . . 15.0 107.084 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.696 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.4 m-85 -89.68 133.03 34.87 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 114.908 1.447 . . . . 15.0 114.908 -163.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 34.8 m -129.94 89.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 CA-C-N 112.646 -2.07 . . . . 15.0 108.26 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -90.06 120.23 31.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.323 -0.992 . . . . 15.0 108.323 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.66 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.3 m170 -83.16 -16.99 44.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.701 -0.681 . . . . 15.0 110.939 -172.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.446 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 95.2 m-20 -81.94 -59.94 2.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.35 . . . . 15.0 110.681 -175.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.428 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 30.1 m-80 -86.05 -14.81 43.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.175 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.633 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 28.9 ttm180 61.28 75.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.164 -0.925 . . . . 15.0 110.389 -176.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 33.0 p -137.95 149.98 46.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.133 -0.939 . . . . 15.0 110.522 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.3 m -128.58 115.43 18.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.31 -0.405 . . . . 15.0 110.529 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 14.2 mm100 -133.9 138.41 45.53 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.394 -0.366 . . . . 15.0 110.682 -174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -80.75 -14.97 57.63 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.864 0.364 . . . . 15.0 111.552 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 17.6 m -80.01 117.0 20.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.783 0.325 . . . . 15.0 111.339 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.82 128.11 31.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 15.0 110.203 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 60.6 Cg_endo -73.44 -15.13 25.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.961 2.44 . . . . 15.0 113.915 -175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.495 ' HD3' ' HG2' ' A' ' 311' ' ' PRO . 0.8 OUTLIER -88.61 -24.11 22.9 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.075 -0.391 . . . . 15.0 110.146 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.867 -0.587 . . . . 15.0 110.129 179.296 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.609 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 120.684 0.278 . . . . 15.0 110.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.632 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 28.2 p -62.69 168.94 3.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.754 -0.657 . . . . 15.0 111.762 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.632 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 81.7 Cg_exo -48.59 140.11 22.48 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.124 2.55 . . . . 15.0 113.483 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 306' ' ' THR . 37.3 Cg_endo -63.76 137.67 59.83 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.137 2.558 . . . . 15.0 113.698 -170.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 306' ' ' THR . 27.1 Cg_exo -64.23 171.85 7.2 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.791 2.994 . . . . 15.0 112.83 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.25 162.38 14.79 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.275 -0.639 . . . . 15.0 109.275 172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 299' ' ' VAL . 4.7 p90 -89.92 131.48 35.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.242 1.02 . . . . 15.0 111.595 -173.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.9 mt -129.9 160.95 62.55 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 113.479 -1.691 . . . . 15.0 107.807 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.487 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.0 Cg_exo -87.52 158.26 7.91 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 120.856 1.037 . . . . 15.0 110.205 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.551 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 69.1 Cg_endo -89.07 134.57 2.59 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.874 1.716 . . . . 15.0 115.082 -147.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.554 ' H ' ' HE ' ' A' ' 289' ' ' ARG . 20.1 pt-20 -105.94 99.04 8.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.247 -1.342 . . . . 15.0 109.832 176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.449 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 20.7 t70 -147.29 112.97 4.09 Favored Pre-proline 0 C--N 1.317 -0.827 0 O-C-N 121.033 -1.042 . . . . 15.0 111.574 -169.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 3.4 Cg_exo -80.96 88.12 1.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.443 2.762 . . . . 15.0 111.658 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.168 -0.469 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 311' ' ' PRO . 7.1 mp . . . . . 0 N--CA 1.482 1.126 0 CA-C-O 120.458 0.171 . . . . 15.0 111.125 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 141.05 -78.66 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.9 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -89.77 148.18 4.93 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.875 2.384 . . . . 15.0 114.023 -170.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 283' ' ' PRO . 19.7 tp -113.83 113.31 47.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.56 174.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 25.7 Cg_exo -63.62 134.84 46.15 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 123.024 2.483 . . . . 15.0 112.734 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.41 122.28 11.4 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.842 2.362 . . . . 15.0 111.755 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.99 -8.63 25.32 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 111.404 -0.678 . . . . 15.0 111.404 -175.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.719 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.3 m95 -90.0 109.53 20.56 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.407 -0.396 . . . . 15.0 110.466 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.75 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.8 mp0 -90.09 115.81 27.63 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.061 -1.089 . . . . 15.0 108.061 172.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 296' ' ' ILE . 2.1 p -89.74 103.24 13.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.679 -0.691 . . . . 15.0 109.259 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.863 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -97.32 93.29 6.42 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 108.311 -0.996 . . . . 15.0 108.311 -175.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.25 128.43 42.08 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.926 -1.034 . . . . 15.0 110.32 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.7 p -114.47 143.21 45.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.961 0.41 . . . . 15.0 111.805 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 13.9 t -63.01 -15.09 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 114.963 -1.017 . . . . 15.0 110.998 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.1 t -57.71 -14.78 6.19 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.812 -0.631 . . . . 15.0 110.354 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.46 40.21 5.76 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.884 -0.598 . . . . 15.0 113.221 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -150.31 136.05 18.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.05 0.452 . . . . 15.0 110.766 170.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.703 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -89.9 139.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.918 -1.141 . . . . 15.0 107.918 173.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.863 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.47 130.38 13.36 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.046 -1.094 . . . . 15.0 108.046 -173.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.719 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.92 137.71 32.11 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 115.315 1.598 . . . . 15.0 115.315 -168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.9 m -136.04 89.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 112.429 -2.169 . . . . 15.0 108.552 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.89 121.45 32.02 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.492 -0.929 . . . . 15.0 108.492 178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 17.7 m170 -81.53 -15.18 55.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.689 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -75.33 -63.56 1.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.309 -0.405 . . . . 15.0 110.356 -173.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -92.93 -15.0 26.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.492 . . . . 15.0 110.76 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 43.7 ttp180 65.41 82.04 0.19 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.725 -0.67 . . . . 15.0 109.941 -171.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 125.12 23.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.221 -0.9 . . . . 15.0 110.352 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -105.55 116.5 32.05 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.824 0.345 . . . . 15.0 110.344 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -128.19 132.06 48.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.932 -175.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' B' ' 221' ' ' ASP . 1.1 m-85 -79.78 -14.69 58.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.19 0.519 . . . . 15.0 110.39 170.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 39.9 p -77.77 120.51 22.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.589 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 296' ' ' ILE . 7.2 t70 -117.42 131.63 23.95 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 15.0 111.786 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.661 ' HA ' HD13 ' A' ' 279' ' ' LEU . 84.5 Cg_endo -83.21 -14.93 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.166 2.578 . . . . 15.0 113.544 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -68.16 -39.34 82.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.92 0.39 . . . . 15.0 110.321 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.468 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.9 mt . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.717 -0.659 . . . . 15.0 110.006 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 308' ' ' PHE . 7.1 t0 . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 108.496 -0.928 . . . . 15.0 108.496 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.544 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 15.0 t -79.95 159.01 71.94 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 109.352 -0.61 . . . . 15.0 109.352 -176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.544 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 95.8 Cg_exo -48.45 146.37 10.52 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.134 1.889 . . . . 15.0 112.145 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.51 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 1.3 Cg_endo -48.71 121.7 6.92 Favored 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 123.824 3.016 . . . . 15.0 114.491 -162.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 5.5 Cg_exo -75.69 -179.81 5.5 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 124.792 3.661 . . . . 15.0 113.085 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.57 153.67 31.25 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.531 -0.544 . . . . 15.0 109.531 171.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.667 ' HA ' HG12 ' A' ' 299' ' ' VAL . 11.3 p90 -89.74 144.18 26.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.928 0.87 . . . . 15.0 112.183 -171.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.47 ' O ' HG21 ' A' ' 299' ' ' VAL . 95.7 mt -130.43 161.36 61.03 Favored Pre-proline 0 C--O 1.214 -0.804 0 CA-C-N 114.065 -1.425 . . . . 15.0 110.233 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.478 ' HA ' ' NE2' ' A' ' 301' ' ' HIS . 2.6 Cg_exo -87.83 149.63 7.2 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 120.863 1.042 . . . . 15.0 110.839 176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.467 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 28.5 Cg_endo -89.61 153.36 5.22 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.452 2.101 . . . . 15.0 116.301 -146.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.574 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.2 pt-20 -125.66 117.8 24.29 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 113.774 -1.557 . . . . 15.0 108.804 172.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -150.07 108.52 3.23 Favored Pre-proline 0 C--O 1.234 0.256 0 O-C-N 121.717 -0.615 . . . . 15.0 110.745 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -95.19 67.65 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.254 2.636 . . . . 15.0 112.282 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.292 -0.413 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 111.86 0.318 . . . . 15.0 111.86 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 154.4 -57.7 0.4 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.062 -1.542 . . . . 15.0 115.353 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.68 139.74 3.4 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.113 1.876 . . . . 15.0 114.599 -166.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 24.0 tp -101.38 117.55 61.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.085 -0.962 . . . . 15.0 109.492 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.469 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 26.0 Cg_exo -65.11 157.3 58.11 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.213 2.609 . . . . 15.0 113.112 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 13.8 Cg_exo -67.8 132.38 26.57 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.579 2.186 . . . . 15.0 112.349 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 93.69 0.46 66.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.69 -0.766 . . . . 15.0 112.206 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.706 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.3 m95 -89.86 105.46 17.82 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.076 0.465 . . . . 15.0 111.072 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.746 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.2 mp0 -89.88 119.71 30.49 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.955 -1.128 . . . . 15.0 107.955 170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.875 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.78 106.43 17.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.796 -0.638 . . . . 15.0 109.928 -174.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.608 ' HB2' HG22 ' A' ' 299' ' ' VAL . 0.0 OUTLIER -100.39 93.05 5.45 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.567 -1.272 . . . . 15.0 107.567 -176.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 34.8 t -105.52 109.89 22.02 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.827 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.441 ' HA ' HH12 ' A' ' 289' ' ' ARG . 45.9 p -90.02 142.89 27.27 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.044 0.45 . . . . 15.0 111.659 -173.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.22 -14.74 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 115.028 -0.987 . . . . 15.0 112.083 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.475 ' HB3' ' HD3' ' A' ' 295' ' ' ARG . 24.9 t -59.89 -14.76 16.89 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.224 -0.444 . . . . 15.0 110.511 174.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.57 44.98 4.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.989 -0.624 . . . . 15.0 112.638 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' A' ' 293' ' ' SER . 0.0 OUTLIER -148.61 136.09 20.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.852 0.358 . . . . 15.0 110.453 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.875 HD11 HG23 ' A' ' 288' ' ' VAL . 7.5 tp -89.77 139.98 16.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.66 -0.867 . . . . 15.0 108.66 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 289' ' ' ARG . 2.2 p90 -150.33 125.21 9.84 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.243 -1.391 . . . . 15.0 107.243 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.6 m-85 -91.46 136.66 32.95 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 114.455 1.28 . . . . 15.0 114.455 -169.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.608 HG22 ' HB2' ' A' ' 289' ' ' ARG . 31.5 m -130.09 89.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 112.642 -2.072 . . . . 15.0 108.102 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.91 121.13 33.95 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.136 -0.938 . . . . 15.0 108.956 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.746 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 7.9 m170 -89.0 -7.13 56.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.494 . . . . 15.0 110.216 -175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -83.37 -62.99 1.44 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 15.0 110.499 -175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -92.41 -14.89 27.94 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.874 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.499 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 74.8 ttt180 68.54 81.25 0.19 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.619 0.724 . . . . 15.0 109.802 -174.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.64 25.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.215 -0.902 . . . . 15.0 110.525 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 6.6 m -112.46 120.1 40.48 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.65 -0.5 . . . . 15.0 109.65 174.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -131.0 137.7 49.34 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.76 -0.2 . . . . 15.0 111.501 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.439 ' HE2' ' O ' ' B' ' 222' ' ' THR . 6.9 m-85 -91.48 -14.87 29.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.767 0.318 . . . . 15.0 111.82 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.8 m -86.08 112.77 21.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.449 -0.341 . . . . 15.0 110.282 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.51 ' HB2' HG12 ' A' ' 296' ' ' ILE . 13.9 t70 -93.84 127.69 44.5 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.042 0.448 . . . . 15.0 111.63 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.5 -14.77 19.98 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.505 2.803 . . . . 15.0 113.287 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -77.07 -36.94 55.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.906 0.384 . . . . 15.0 110.018 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.532 -0.747 . . . . 15.0 110.688 177.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 40.2 t0 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.591 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 42.6 p -60.67 160.46 19.27 Favored Pre-proline 0 C--O 1.221 -0.438 0 C-N-CA 123.185 0.594 . . . . 15.0 111.073 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.6 Cg_endo -48.61 130.36 22.02 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.071 2.514 . . . . 15.0 112.746 -172.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.552 ' HB2' ' CG2' ' A' ' 306' ' ' THR . 30.8 Cg_endo -64.92 147.62 89.35 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.658 2.238 . . . . 15.0 113.771 -170.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 90.1 Cg_endo -91.0 -179.9 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.878 3.052 . . . . 15.0 112.99 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.97 154.54 15.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.204 173.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.724 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 17.5 p90 -89.95 144.41 25.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.94 0.876 . . . . 15.0 111.782 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.0 mp -130.31 161.1 62.41 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.148 -1.387 . . . . 15.0 108.504 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.2 Cg_exo -87.56 143.74 6.38 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 N-CA-C 109.477 -1.009 . . . . 15.0 109.477 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.573 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 51.2 Cg_endo -89.53 138.37 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.706 1.604 . . . . 15.0 115.735 -143.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.446 ' HG2' ' NE ' ' A' ' 289' ' ' ARG . 6.3 pt-20 -89.93 99.1 12.18 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.774 -1.103 . . . . 15.0 109.549 175.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 25.3 t70 -150.3 110.01 3.21 Favored Pre-proline 0 C--N 1.316 -0.852 0 O-C-N 121.131 -0.98 . . . . 15.0 111.35 -169.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 9.4 Cg_endo -88.86 82.69 0.7 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.462 2.775 . . . . 15.0 112.027 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.435 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 279' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 110.12 -0.326 . . . . 15.0 110.12 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 162.48 -56.32 0.3 Allowed Glycine 0 CA--C 1.525 0.68 0 C-N-CA 119.911 -1.138 . . . . 15.0 114.128 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -89.66 148.16 5.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.204 1.936 . . . . 15.0 113.889 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 312' ' ' ARG . 38.3 tp -114.7 119.66 39.07 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.347 -0.842 . . . . 15.0 109.441 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 39.3 Cg_exo -61.61 137.42 68.91 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.13 2.554 . . . . 15.0 112.657 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.36 134.62 64.91 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.876 2.384 . . . . 15.0 112.153 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.66 -1.53 52.73 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.879 -0.676 . . . . 15.0 111.729 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.718 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.9 m95 -89.81 108.75 19.88 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.012 0.435 . . . . 15.0 110.933 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.621 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.0 OUTLIER -92.69 122.94 35.59 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 172.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CE1' ' A' ' 298' ' ' PHE . 16.1 m -89.9 109.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.756 0.789 . . . . 15.0 109.525 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.713 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.33 94.11 7.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.065 -1.087 . . . . 15.0 108.065 179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.26 116.09 32.0 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.698 -1.137 . . . . 15.0 110.523 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 54.3 p -96.5 145.02 26.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.901 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 28.5 m -59.8 -15.02 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.997 -0.547 . . . . 15.0 111.563 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.7 t -58.51 -14.36 7.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.709 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.12 44.78 4.64 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.959 -0.638 . . . . 15.0 112.214 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.594 ' HD3' ' OD2' ' B' ' 221' ' ' ASP . 14.5 ptt-85 -147.75 124.61 11.25 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.054 0.454 . . . . 15.0 110.344 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.476 HD11 ' HB ' ' A' ' 288' ' ' VAL . 0.2 OUTLIER -92.23 132.41 36.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.093 -1.447 . . . . 15.0 107.093 171.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.713 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.2 p90 -150.33 135.04 17.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.958 -1.127 . . . . 15.0 107.958 -172.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.718 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.89 137.46 32.32 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 115.639 1.718 . . . . 15.0 115.639 -165.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.6 m -136.41 89.71 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.194 -2.275 . . . . 15.0 108.123 178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.655 ' HB3' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -92.82 119.3 32.02 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.305 -0.628 . . . . 15.0 109.305 -178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.676 ' HD2' ' CD1' ' B' ' 227' ' ' TYR . 7.8 m170 -85.13 -11.08 55.95 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.271 -175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -84.01 -57.83 3.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.162 -173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -94.66 -14.76 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.242 -0.183 . . . . 15.0 111.33 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 40.4 ttt180 67.12 89.44 0.1 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.394 0.678 . . . . 15.0 110.428 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 300' ' ' ASP . 6.3 t -150.03 150.02 31.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.593 -0.731 . . . . 15.0 109.964 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.647 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.5 p -131.39 117.64 19.16 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.294 -0.412 . . . . 15.0 110.476 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 13.3 mm100 -141.89 131.96 24.67 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.426 -0.352 . . . . 15.0 111.817 -171.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.404 ' CD2' ' HD3' ' B' ' 224' ' ' PRO . 2.7 m-85 -73.75 -14.82 61.19 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.108 0.48 . . . . 15.0 110.745 170.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 20.3 p -79.54 109.16 13.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.83 -0.623 . . . . 15.0 111.8 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -96.77 127.6 38.77 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 15.0 109.944 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.22 -14.71 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.317 2.678 . . . . 15.0 114.262 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.519 ' HD3' HD22 ' A' ' 282' ' ' LEU . 91.0 mtm180 -68.63 -36.1 78.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.919 0.711 . . . . 15.0 112.919 -169.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.565 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.347 -0.835 . . . . 15.0 110.571 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.594 ' OD2' ' HD3' ' A' ' 295' ' ' ARG . 2.9 m-20 . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.009 0.433 . . . . 15.0 110.334 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.475 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 13.8 t -68.0 151.93 96.81 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.268 -0.878 . . . . 15.0 111.145 -175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.475 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 99.3 Cg_exo -48.5 153.55 3.25 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.365 2.71 . . . . 15.0 113.303 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.611 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 8.8 Cg_endo -49.08 120.13 5.19 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.971 3.114 . . . . 15.0 114.465 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.553 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 66.2 Cg_exo -56.48 176.51 0.2 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 124.155 3.237 . . . . 15.0 113.084 172.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.17 16.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.401 -0.592 . . . . 15.0 109.401 171.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.789 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.0 p90 -89.8 134.21 34.3 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.499 1.143 . . . . 15.0 112.37 -171.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.456 ' O ' HG21 ' A' ' 299' ' ' VAL . 90.4 mt -130.24 160.93 63.23 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 113.377 -1.738 . . . . 15.0 108.325 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.82 148.4 7.1 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 120.747 0.965 . . . . 15.0 110.83 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 25.2 Cg_endo -89.86 152.63 4.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.458 2.106 . . . . 15.0 116.562 -145.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.595 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.2 pt-20 -117.77 129.48 55.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.75 -1.568 . . . . 15.0 107.884 168.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -149.97 114.72 3.42 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 118.376 0.535 . . . . 15.0 110.069 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.76 -73.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.18 2.586 . . . . 15.0 112.607 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.478 -0.328 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.837 0.351 . . . . 15.0 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -166.02 171.36 41.1 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.195 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -89.92 146.16 4.61 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.205 2.603 . . . . 15.0 112.822 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.823 HD22 ' HD2' ' A' ' 312' ' ' ARG . 23.5 tp -130.14 102.66 17.2 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.252 -0.431 . . . . 15.0 110.102 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 2.7 Cg_exo -76.92 135.71 15.91 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.979 2.453 . . . . 15.0 112.378 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 116.59 3.18 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.796 2.331 . . . . 15.0 111.561 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 125.95 -13.14 7.2 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.478 -1.049 . . . . 15.0 110.478 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.674 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 4.4 m95 -89.68 99.93 12.83 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.24 -0.652 . . . . 15.0 109.24 174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.63 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 0.4 OUTLIER -91.01 125.64 35.86 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.613 -0.721 . . . . 15.0 109.53 178.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.599 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 34.9 m -89.72 100.55 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-O 121.793 0.806 . . . . 15.0 109.61 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.989 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.32 99.27 12.27 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.5 -1.296 . . . . 15.0 107.5 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 12.2 p -98.17 142.34 29.97 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.54 -1.209 . . . . 15.0 110.003 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 24.6 p -128.91 147.92 50.87 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.718 -0.393 . . . . 15.0 110.801 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 35.9 m -61.46 -14.75 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.956 0.724 . . . . 15.0 112.956 -171.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 18.5 m -62.1 -14.53 37.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.837 0.351 . . . . 15.0 110.957 174.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.09 32.99 9.19 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.891 -0.484 . . . . 15.0 111.891 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.626 HH21 ' HZ ' ' A' ' 308' ' ' PHE . 7.5 ptm180 -130.83 115.55 16.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.089 0.471 . . . . 15.0 110.658 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.411 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.91 141.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.521 -1.288 . . . . 15.0 107.521 173.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.989 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.8 p90 -150.46 131.94 14.75 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 106.979 -1.489 . . . . 15.0 106.979 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.7 m-85 -89.91 132.59 35.22 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 114.777 1.399 . . . . 15.0 114.777 -166.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.4 m -132.89 89.91 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 CA-C-N 112.397 -2.183 . . . . 15.0 108.236 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.611 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.86 124.08 34.37 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.236 -1.024 . . . . 15.0 108.236 178.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.686 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 50.6 m170 -78.98 -24.57 43.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.01 -0.995 . . . . 15.0 112.616 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.33 -33.5 11.04 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.561 0.578 . . . . 15.0 112.561 -171.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.611 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 69.8 m-20 -100.13 -14.91 18.36 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.24 -0.584 . . . . 15.0 111.625 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? 67.95 53.78 0.64 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.232 0.539 . . . . 15.0 110.807 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 12.0 m -104.98 136.6 44.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.767 -0.652 . . . . 15.0 110.881 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 19.9 p -129.9 117.02 19.5 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.357 -0.383 . . . . 15.0 111.264 -178.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 17.1 mt-30 -148.15 134.85 19.91 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.626 ' HZ ' HH21 ' A' ' 295' ' ' ARG . 5.8 m-85 -74.47 -24.01 58.96 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.984 -0.447 . . . . 15.0 112.029 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 10.5 t -73.47 125.79 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.099 0.476 . . . . 15.0 110.478 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -115.94 117.79 39.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.956 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.28 -14.74 28.46 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.543 2.828 . . . . 15.0 113.22 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.823 ' HD2' HD22 ' A' ' 282' ' ' LEU . 2.9 mmp_? -66.11 -14.87 62.5 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.856 0.687 . . . . 15.0 112.856 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.637 -0.697 . . . . 15.0 110.547 178.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 308' ' ' PHE . 2.7 p-10 . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 121.101 0.477 . . . . 15.0 111.029 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.9 p -86.41 151.76 54.0 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.673 -0.694 . . . . 15.0 109.694 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.71 146.11 11.73 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.154 2.569 . . . . 15.0 112.737 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.7 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.8 Cg_endo -51.91 119.77 6.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.293 2.662 . . . . 15.0 112.986 -168.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.566 ' HG2' ' CE2' ' A' ' 297' ' ' TYR . 67.3 Cg_endo -73.32 -179.9 4.85 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.418 2.745 . . . . 15.0 112.639 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.15 158.16 4.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.175 -0.466 . . . . 15.0 110.721 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.702 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -89.89 135.01 33.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 15.0 112.424 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.0 mm? -130.12 160.88 63.26 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 114.034 -1.439 . . . . 15.0 108.264 176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 5.8 Cg_exo -88.0 151.92 7.07 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 120.763 0.975 . . . . 15.0 110.312 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.63 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 41.6 Cg_endo -89.78 138.3 2.99 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.06 1.84 . . . . 15.0 115.91 -147.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.453 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 16.5 pt-20 -105.03 118.55 36.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.58 -1.267 . . . . 15.0 107.58 165.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -137.87 114.18 9.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 O-C-N 121.95 -0.469 . . . . 15.0 110.766 -171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.42 77.19 4.05 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.1 2.533 . . . . 15.0 111.792 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.12 -0.491 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.263 0.078 . . . . 15.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.98 -61.98 0.58 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.775 -1.202 . . . . 15.0 114.237 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -89.67 150.08 5.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.68 2.253 . . . . 15.0 114.0 -168.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 24.7 tp -116.63 116.86 38.48 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.341 -0.845 . . . . 15.0 109.802 178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.77 138.75 38.54 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.963 2.442 . . . . 15.0 112.559 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.19 130.13 34.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.779 2.32 . . . . 15.0 111.733 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.0 -14.31 23.89 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.4 m95 -90.0 106.3 18.38 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.218 -0.491 . . . . 15.0 111.006 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.694 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.2 mp0 -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.559 -0.904 . . . . 15.0 108.559 171.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.2 p -90.35 104.34 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.689 -0.687 . . . . 15.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -96.64 96.35 8.57 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.511 -0.922 . . . . 15.0 108.511 -176.283 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.97 122.67 43.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.928 -0.578 . . . . 15.0 110.786 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 39.8 p -103.21 150.06 24.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.398 -0.365 . . . . 15.0 111.558 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.14 -14.89 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.969 -175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.599 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 2.4 m -60.81 -14.47 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.233 -0.439 . . . . 15.0 111.088 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.15 36.52 7.08 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.268 -0.733 . . . . 15.0 111.268 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.599 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 31.9 ptt180 -142.09 123.16 14.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.31 0.576 . . . . 15.0 110.766 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.97 139.51 17.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.42 -0.809 . . . . 15.0 108.882 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.8 p90 -150.63 133.28 15.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.823 -1.177 . . . . 15.0 107.823 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.757 ' CB ' ' HG2' ' A' ' 307' ' ' GLN . 2.1 m-85 -93.09 136.99 32.84 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 115.214 1.561 . . . . 15.0 115.214 -167.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.745 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.3 m -127.98 91.95 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 112.911 -1.949 . . . . 15.0 109.098 177.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.659 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.82 123.04 33.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.07 -1.456 . . . . 15.0 107.07 173.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.694 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 29.2 m170 -86.66 -19.09 29.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.398 -0.819 . . . . 15.0 112.18 -166.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -98.78 -35.84 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.176 -0.61 . . . . 15.0 112.098 -172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 93.6 m-20 -93.3 -15.0 26.28 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.654 -0.419 . . . . 15.0 110.618 173.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 304' ' ' ARG . 41.7 ttp180 59.01 79.02 0.23 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.622 0.725 . . . . 15.0 111.265 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.778 HG23 HE22 ' A' ' 307' ' ' GLN . 6.2 t -150.08 149.94 31.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.562 -0.745 . . . . 15.0 110.524 175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 3.7 p -120.42 114.78 22.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.832 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.778 HE22 HG23 ' A' ' 305' ' ' THR . 0.0 OUTLIER -122.44 132.23 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.435 0.531 . . . . 15.0 112.435 -174.193 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -83.0 -14.8 53.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.312 -0.403 . . . . 15.0 110.424 171.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.0 m -78.8 106.2 10.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 15.0 110.46 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.487 ' OD2' HD13 ' A' ' 313' ' ' LEU . 15.3 t70 -96.9 136.02 21.81 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.497 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -84.21 -14.67 6.98 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.472 2.782 . . . . 15.0 113.456 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.686 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 30.0 mmm180 -68.86 -48.27 63.85 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.855 0.316 . . . . 15.0 111.855 -174.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 117.969 -1.015 . . . . 15.0 111.391 177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.236 -0.653 . . . . 15.0 109.236 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 9.2 p -64.89 164.67 19.78 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 119.359 -0.353 . . . . 15.0 110.574 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.654 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 5.9 Cg_endo -48.81 133.59 27.6 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.97 2.447 . . . . 15.0 112.669 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.459 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 18.4 Cg_endo -61.31 139.42 82.84 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.699 2.266 . . . . 15.0 113.582 -168.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 27.5 Cg_exo -63.03 179.03 0.86 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 123.667 2.911 . . . . 15.0 112.41 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -68.04 161.1 27.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.028 -0.73 . . . . 15.0 109.028 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.569 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -89.7 125.31 35.22 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.988 0.899 . . . . 15.0 111.145 -173.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.745 ' O ' HG21 ' A' ' 299' ' ' VAL . 94.1 mt -130.24 160.9 63.39 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 114.547 -1.206 . . . . 15.0 108.179 174.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.6 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.65 160.05 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.402 1.401 . . . . 15.0 111.35 -172.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 69.6 Cg_endo -89.47 131.49 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.494 2.129 . . . . 15.0 116.308 -143.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.674 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 24.7 pt-20 -115.51 140.93 48.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 113.428 -1.715 . . . . 15.0 107.725 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 12.1 t70 -141.16 119.58 8.03 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.907 0.384 . . . . 15.0 110.403 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 68.7 Cg_endo -92.51 65.81 0.73 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.209 2.606 . . . . 15.0 112.165 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 116.221 -0.445 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.651 0.263 . . . . 15.0 110.4 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 174.93 -171.21 44.4 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.589 -0.815 . . . . 15.0 112.321 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -89.8 135.93 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.067 2.512 . . . . 15.0 112.513 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 25.3 tp -110.78 117.55 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.253 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.1 Cg_exo -67.17 139.06 49.22 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.042 2.494 . . . . 15.0 112.138 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.76 120.94 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.669 2.246 . . . . 15.0 111.946 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.93 -11.98 17.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.97 -0.633 . . . . 15.0 111.629 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.709 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.8 m95 -89.87 109.73 20.72 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.14 0.495 . . . . 15.0 111.45 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.669 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.39 119.2 36.66 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.361 -0.836 . . . . 15.0 108.843 170.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 296' ' ' ILE . 1.3 p -89.88 104.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.3 0.571 . . . . 15.0 110.19 -177.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.964 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -98.14 103.03 14.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.225 -0.657 . . . . 15.0 109.225 -174.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -90.89 140.97 29.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.694 -0.685 . . . . 15.0 110.508 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 37.7 p -131.01 149.21 52.73 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 120.919 0.39 . . . . 15.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.0 p -66.03 -15.01 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.257 -0.883 . . . . 15.0 112.674 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 44.9 p -60.58 -14.91 22.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 15.0 110.759 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.58 45.21 4.37 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.709 -0.557 . . . . 15.0 111.709 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -148.76 134.52 18.88 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.15 0.5 . . . . 15.0 110.812 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.59 139.28 17.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.616 -1.253 . . . . 15.0 107.616 170.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.964 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.5 132.26 14.99 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.932 -1.136 . . . . 15.0 107.932 -173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.709 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.0 m-85 -89.91 138.04 31.83 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 115.429 1.64 . . . . 15.0 115.429 -168.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.748 HG21 ' O ' ' B' ' 228' ' ' LEU . 28.2 m -133.09 90.06 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.729 0 CA-C-N 112.269 -2.241 . . . . 15.0 108.901 178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -89.79 122.53 32.95 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.377 -1.712 . . . . 15.0 106.377 176.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.669 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 34.9 m170 -85.29 -20.33 30.2 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.372 -0.831 . . . . 15.0 112.8 -163.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -100.04 -33.37 10.51 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.74 -0.784 . . . . 15.0 111.839 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.568 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 24.4 m-80 -89.73 -27.44 20.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.462 -0.495 . . . . 15.0 109.968 172.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 67.59 83.09 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.925 0.765 . . . . 15.0 110.545 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.477 HG22 ' OD2' ' A' ' 300' ' ' ASP . 4.5 t -143.51 150.12 38.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.263 -0.88 . . . . 15.0 110.39 177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.654 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.3 p -120.02 111.57 18.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 15.0 110.894 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 16.6 mm-40 -121.91 126.48 48.77 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.012 -0.54 . . . . 15.0 112.11 -171.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.415 ' HE2' ' O ' ' B' ' 222' ' ' THR . 1.3 m-85 -84.81 -14.77 47.07 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.973 -0.454 . . . . 15.0 111.49 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 30.5 m -81.93 118.16 22.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.76 0.315 . . . . 15.0 110.485 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.459 ' OD1' ' HD2' ' A' ' 311' ' ' PRO . 19.9 t0 -112.04 133.22 21.71 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.341 -175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.459 ' HD2' ' OD1' ' A' ' 310' ' ' ASP . 98.4 Cg_endo -89.74 -14.63 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 15.0 113.457 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.788 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 27.4 mmm180 -82.03 -37.99 25.67 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -171.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 C--O 1.249 1.031 0 CA-C-O 119.314 -0.374 . . . . 15.0 111.963 -175.175 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.415 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 14.2 p -66.46 158.68 77.36 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 119.322 -0.37 . . . . 15.0 110.741 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -48.8 138.82 25.72 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.883 2.389 . . . . 15.0 113.095 -171.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 34.9 Cg_endo -65.05 139.12 59.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.627 2.218 . . . . 15.0 113.06 -172.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.569 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.0 Cg_exo -66.22 178.89 2.22 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.396 2.731 . . . . 15.0 111.912 176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.3 164.31 13.76 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.998 -0.742 . . . . 15.0 108.998 170.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.686 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.8 p90 -89.82 125.42 35.31 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.735 0.778 . . . . 15.0 110.948 -173.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.748 ' O ' HG21 ' A' ' 299' ' ' VAL . 7.0 mp -130.11 160.64 64.4 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.698 -1.137 . . . . 15.0 108.219 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.583 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.83 160.15 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 121.372 1.381 . . . . 15.0 111.903 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.904 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 79.2 Cg_endo -89.75 144.19 4.44 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.331 2.021 . . . . 15.0 115.67 -149.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.524 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.4 pt-20 -118.97 99.94 7.05 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.056 -1.429 . . . . 15.0 109.554 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 18.7 t70 -142.26 120.11 7.41 Favored Pre-proline 0 C--O 1.234 0.258 0 O-C-N 121.888 -0.507 . . . . 15.0 110.35 -176.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 6.0 Cg_exo -79.45 89.31 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.125 2.55 . . . . 15.0 111.869 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.405 -0.361 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 110.31 -0.256 . . . . 15.0 110.31 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 176.71 -70.66 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 C-N-CA 119.734 -1.222 . . . . 15.0 113.876 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -89.85 148.38 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.749 2.299 . . . . 15.0 113.848 -170.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 23.5 tp -108.13 117.47 54.87 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.387 -0.824 . . . . 15.0 109.39 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.36 135.51 54.26 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.677 2.251 . . . . 15.0 112.421 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.25 124.99 14.81 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.835 2.357 . . . . 15.0 112.022 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.79 -3.13 24.47 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.766 -0.731 . . . . 15.0 111.566 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.708 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.68 111.82 22.9 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.011 0.434 . . . . 15.0 110.581 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.546 ' HG3' ' HG3' ' B' ' 230' ' ' PRO . 1.0 OUTLIER -97.17 122.37 40.1 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.295 -1.372 . . . . 15.0 107.295 173.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.654 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.6 m -89.95 112.47 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.079 0.942 . . . . 15.0 109.059 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.774 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.68 96.16 6.91 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.016 -1.105 . . . . 15.0 108.016 -177.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.3 126.71 46.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.304 -0.862 . . . . 15.0 110.825 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.2 p -105.57 147.79 28.01 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.091 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.93 -14.85 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.683 -0.69 . . . . 15.0 111.125 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 23.1 m -58.26 -14.63 7.67 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.322 173.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.18 40.32 5.83 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.217 -0.516 . . . . 15.0 111.941 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.05 125.82 10.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.147 0.499 . . . . 15.0 110.831 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.0 tt -89.83 142.27 13.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 107.897 -1.149 . . . . 15.0 107.897 172.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.774 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.5 p90 -150.28 132.38 15.32 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.241 -1.392 . . . . 15.0 107.241 -173.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.708 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.9 m-85 -89.78 141.4 28.66 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 114.862 1.431 . . . . 15.0 114.862 -165.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' B' ' 227' ' ' TYR . 11.4 m -145.05 90.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 111.991 -2.368 . . . . 15.0 108.541 -177.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.446 ' OD2' ' HB ' ' A' ' 305' ' ' THR . 2.6 p30 -89.55 123.37 33.58 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.516 -0.92 . . . . 15.0 108.516 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.641 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 28.6 m170 -80.97 -16.81 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.165 -0.925 . . . . 15.0 111.083 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -87.72 -46.43 9.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 15.0 111.646 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -95.41 -14.98 23.33 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 121.082 -0.247 . . . . 15.0 111.33 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 61.28 77.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.597 0.713 . . . . 15.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 300' ' ' ASP . 0.2 OUTLIER -141.54 150.16 41.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.246 -0.888 . . . . 15.0 109.898 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 27.3 p -128.61 126.96 41.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.954 0.406 . . . . 15.0 111.121 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 24.5 mm-40 -142.85 144.24 32.43 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.947 -0.569 . . . . 15.0 110.712 -175.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.495 ' HE2' ' O ' ' B' ' 222' ' ' THR . 11.2 m-85 -88.04 -14.91 37.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.161 0.505 . . . . 15.0 110.816 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 8.8 m -75.78 112.56 12.29 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 15.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.86 128.77 46.78 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.542 -0.54 . . . . 15.0 109.542 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.58 ' HD3' ' CZ3' ' A' ' 286' ' ' TRP . 80.0 Cg_endo -79.3 -14.79 13.01 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.494 2.129 . . . . 15.0 113.329 -174.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.573 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 59.9 mtm180 -94.61 -46.25 7.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.993 -0.743 . . . . 15.0 108.993 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 313' ' ' LEU . 2.3 tm? . . . . . 0 C--O 1.248 0.986 0 CA-C-N 114.807 -1.088 . . . . 15.0 109.433 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.495 ' O ' ' HE2' ' A' ' 308' ' ' PHE . 18.5 p -52.45 156.82 2.77 Favored Pre-proline 0 C--O 1.222 -0.377 0 C-N-CA 123.008 0.523 . . . . 15.0 112.022 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -48.78 137.43 27.25 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.868 2.379 . . . . 15.0 112.895 -171.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.493 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 6.6 Cg_endo -53.91 129.96 36.85 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.098 2.532 . . . . 15.0 113.879 -168.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 24.1 Cg_exo -64.8 -179.68 1.06 Allowed 'Trans proline' 0 N--CA 1.474 0.333 0 C-N-CA 124.379 3.386 . . . . 15.0 112.984 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.74 167.01 9.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.385 -0.598 . . . . 15.0 109.385 169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.698 ' HA ' HG12 ' A' ' 299' ' ' VAL . 4.1 p90 -92.83 136.1 33.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.949 0.88 . . . . 15.0 112.636 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.531 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.6 mp -130.34 160.91 63.49 Favored Pre-proline 0 C--O 1.215 -0.741 0 CA-C-N 114.007 -1.451 . . . . 15.0 109.5 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -88.09 160.06 7.19 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.455 1.436 . . . . 15.0 110.236 173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.694 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 60.4 Cg_endo -89.09 132.58 2.3 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 N-CA-C 115.79 1.419 . . . . 15.0 115.79 -152.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.557 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -114.62 128.39 56.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 113.453 -1.703 . . . . 15.0 107.411 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -150.14 119.88 3.8 Favored Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 120.166 -0.614 . . . . 15.0 110.569 -177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.01 -55.56 3.11 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.974 2.449 . . . . 15.0 111.936 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 116.084 -0.507 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.729 -0.471 . . . . 15.0 109.729 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 136.03 -158.11 23.74 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.76 -0.733 . . . . 15.0 112.419 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -93.54 148.75 2.31 Favored 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.877 3.052 . . . . 15.0 113.811 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.734 HD22 ' HD2' ' A' ' 312' ' ' ARG . 38.4 tp -102.47 113.11 66.04 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.203 -0.666 . . . . 15.0 109.203 168.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.0 137.04 36.66 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 15.0 112.435 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 128.95 29.07 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.348 . . . . 15.0 111.683 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.58 -6.07 29.75 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.802 -0.714 . . . . 15.0 111.413 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 5.5 m95 -89.67 111.02 21.87 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.99 0.424 . . . . 15.0 110.578 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.693 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.4 OUTLIER -94.78 120.12 34.49 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.654 -0.869 . . . . 15.0 108.654 174.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.4 m -89.87 111.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.714 -0.847 . . . . 15.0 108.714 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 1.007 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.2 OUTLIER -99.73 103.71 15.38 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.045 -1.094 . . . . 15.0 108.045 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 40.3 t -100.5 139.86 35.58 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.099 -0.955 . . . . 15.0 110.05 -173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 44.9 p -124.95 147.03 49.09 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.887 -0.325 . . . . 15.0 110.751 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.04 -14.78 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.177 -0.919 . . . . 15.0 111.895 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.422 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 0.9 OUTLIER -60.98 -14.92 26.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.956 0.408 . . . . 15.0 111.061 177.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.73 4.95 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.357 -0.697 . . . . 15.0 111.357 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.422 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 24.4 ptt180 -148.51 123.12 9.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.019 0.437 . . . . 15.0 110.673 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.518 HD11 ' HB ' ' A' ' 288' ' ' VAL . 11.0 tt -89.83 142.01 13.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.659 -1.237 . . . . 15.0 107.659 170.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 1.007 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.4 p90 -150.32 131.22 14.22 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.861 -1.533 . . . . 15.0 106.861 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 286' ' ' TRP . 1.9 m-85 -89.89 135.17 33.79 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 114.913 1.449 . . . . 15.0 114.913 -165.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' B' ' 227' ' ' TYR . 28.3 m -132.46 89.85 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.972 0 CA-C-N 112.328 -2.215 . . . . 15.0 108.002 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.485 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.96 123.66 34.06 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.612 -0.884 . . . . 15.0 108.612 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.693 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -86.5 -14.28 43.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 15.0 110.807 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -83.28 -60.72 2.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.752 0.311 . . . . 15.0 110.898 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -90.38 -14.91 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.346 -0.388 . . . . 15.0 110.623 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 43.5 ttp180 67.06 81.17 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.403 -0.817 . . . . 15.0 110.329 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.485 HG22 ' OD2' ' A' ' 300' ' ' ASP . 13.6 t -150.03 150.21 31.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.442 -0.799 . . . . 15.0 110.687 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 5.2 t -116.2 145.59 42.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.047 -0.524 . . . . 15.0 110.295 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 0.0 OUTLIER -150.07 125.73 10.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.573 -175.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.59 -14.96 38.71 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.26 0.467 . . . . 15.0 112.26 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 6.1 t -96.85 118.6 33.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.082 0.468 . . . . 15.0 109.894 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.524 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 15.3 t70 -93.57 130.22 35.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 15.0 111.231 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 -14.57 21.79 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.916 2.411 . . . . 15.0 113.244 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 282' ' ' LEU . 38.8 mtp85 -79.58 -52.23 8.27 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.118 -0.364 . . . . 15.0 111.266 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.524 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.9 mt . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.459 -0.781 . . . . 15.0 112.103 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 23.4 t0 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 110.141 -0.318 . . . . 15.0 110.141 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.4 t -54.81 147.59 31.16 Favored Pre-proline 0 CA--C 1.53 0.212 0 C-N-CA 123.232 0.613 . . . . 15.0 111.003 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.41 132.56 24.62 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 122.949 2.433 . . . . 15.0 112.433 -172.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.62 141.04 78.1 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.035 2.49 . . . . 15.0 114.353 -163.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.1 171.76 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 124.018 3.145 . . . . 15.0 112.63 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.18 166.14 8.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.296 -0.631 . . . . 15.0 109.296 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.695 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.6 p90 -90.06 134.79 34.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.965 0.888 . . . . 15.0 111.585 -174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.528 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.2 mp -130.13 161.02 62.58 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.15 -1.386 . . . . 15.0 108.413 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.442 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.84 145.93 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 120.747 0.965 . . . . 15.0 110.194 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.552 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.1 Cg_endo -89.98 139.93 3.28 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.208 1.939 . . . . 15.0 116.72 -143.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.581 ' CD ' ' HE ' ' A' ' 289' ' ' ARG . 1.6 pm0 -95.36 131.1 41.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.854 -1.521 . . . . 15.0 108.486 163.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 28.6 t70 -150.08 111.09 3.29 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 118.269 0.486 . . . . 15.0 110.833 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 4.9 Cg_exo -78.68 83.74 2.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.137 2.558 . . . . 15.0 111.904 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.198 -0.455 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.799 0.296 . . . . 15.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -91.07 -179.68 42.83 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.532 -0.842 . . . . 15.0 113.166 -175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -89.99 147.16 4.65 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.596 2.864 . . . . 15.0 113.614 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.528 HD22 ' HD2' ' A' ' 312' ' ' ARG . 54.7 tp -104.73 108.08 59.97 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.566 -0.531 . . . . 15.0 109.566 172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.09 140.07 40.58 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 123.056 2.504 . . . . 15.0 112.702 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.12 123.5 12.65 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.431 2.087 . . . . 15.0 111.421 176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.37 -8.77 20.27 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.869 -0.893 . . . . 15.0 110.869 -174.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.645 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 4.4 m95 -89.87 106.13 18.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.198 -0.501 . . . . 15.0 110.507 178.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.686 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -94.2 119.76 33.47 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 108.205 -1.035 . . . . 15.0 108.205 173.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.432 HG12 ' CE1' ' A' ' 298' ' ' PHE . 0.6 OUTLIER -89.62 112.92 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.464 -0.939 . . . . 15.0 108.464 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.69 ' HD2' ' CE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -101.6 100.79 11.24 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 -176.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.5 p -100.65 131.27 46.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.309 -0.86 . . . . 15.0 110.679 -173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.8 p -120.94 143.72 48.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.84 0.353 . . . . 15.0 111.639 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.1 -14.96 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 115.178 -0.919 . . . . 15.0 112.573 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.2 m -58.29 -15.09 8.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.888 0.375 . . . . 15.0 111.134 174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.17 44.83 4.61 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.708 -0.758 . . . . 15.0 111.621 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 36.8 ptt180 -149.9 127.98 11.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.988 0.423 . . . . 15.0 110.725 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.79 134.81 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.331 -1.359 . . . . 15.0 107.331 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.69 ' CE1' ' HD2' ' A' ' 289' ' ' ARG . 3.0 p90 -150.44 128.17 11.65 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.67 -1.233 . . . . 15.0 107.67 -174.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.645 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -89.75 143.93 26.39 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 114.413 1.264 . . . . 15.0 114.413 -166.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 227' ' ' TYR . 16.1 m -137.21 89.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-N 111.909 -2.405 . . . . 15.0 107.653 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -92.39 119.9 32.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.598 -0.89 . . . . 15.0 108.598 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.698 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 20.3 m170 -81.24 -16.75 51.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.213 -0.903 . . . . 15.0 111.078 -171.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.17 -54.81 3.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.696 0.284 . . . . 15.0 111.486 -172.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.437 ' HB3' ' OD2' ' A' ' 300' ' ' ASP . 10.8 t30 -86.25 -14.85 42.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.94 0.4 . . . . 15.0 110.081 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.03 53.34 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.355 -0.838 . . . . 15.0 110.329 175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.65 150.21 48.39 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.92 0.711 . . . . 15.0 112.92 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 35.3 p -115.86 143.97 44.67 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.305 -0.861 . . . . 15.0 110.666 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.574 HE21 HG23 ' A' ' 309' ' ' THR . 40.2 tt0 -150.08 120.16 7.22 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.484 0.549 . . . . 15.0 112.484 -171.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -74.56 -14.91 60.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.912 1.078 . . . . 15.0 113.912 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . 0.574 HG23 HE21 ' A' ' 307' ' ' GLN . 8.8 t -105.93 128.3 53.7 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.103 -0.639 . . . . 15.0 110.883 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -95.81 127.36 41.57 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.17 0.51 . . . . 15.0 109.934 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.85 -15.02 24.0 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.302 2.668 . . . . 15.0 113.452 -172.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.528 ' HD2' HD22 ' A' ' 282' ' ' LEU . 19.5 mtp180 -76.88 -42.27 40.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 15.0 110.873 -174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.897 -0.573 . . . . 15.0 110.57 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 3.0 m-20 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.718 0.294 . . . . 15.0 110.259 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.564 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 25.5 p -57.04 157.22 11.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 15.0 111.917 -176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 6.2 Cg_endo -48.71 143.34 16.84 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.602 2.868 . . . . 15.0 112.775 -170.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 10.9 Cg_endo -53.4 131.32 42.9 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.404 2.736 . . . . 15.0 113.735 -168.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.589 ' O ' HG21 ' A' ' 306' ' ' THR . 36.2 Cg_exo -63.36 -179.96 0.75 Allowed 'Trans proline' 0 N--CA 1.472 0.246 0 C-N-CA 123.995 3.13 . . . . 15.0 112.816 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.11 160.05 19.08 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.189 -0.671 . . . . 15.0 109.189 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.741 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -90.97 134.54 34.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.163 0.983 . . . . 15.0 111.781 -173.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.3 mp -130.14 161.02 62.59 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.263 -1.335 . . . . 15.0 108.148 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.482 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 4.9 Cg_exo -87.7 153.13 7.48 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 119.938 1.014 . . . . 15.0 110.284 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.645 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 142.29 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.991 1.794 . . . . 15.0 116.022 -145.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.451 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.4 pt-20 -120.98 131.81 54.54 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.951 -1.477 . . . . 15.0 109.457 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -150.02 103.43 3.18 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.268 -0.642 . . . . 15.0 109.268 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.64 93.26 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.878 2.385 . . . . 15.0 112.465 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.248 -0.433 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 312' ' ' ARG . 2.1 pt? . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.247 -0.279 . . . . 15.0 110.247 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 137.25 -96.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.286 -0.959 . . . . 15.0 113.393 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -89.79 144.19 4.4 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.962 2.441 . . . . 15.0 113.972 -172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.453 HD13 ' HD3' ' A' ' 312' ' ' ARG . 24.6 tp -114.07 119.04 41.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.713 -0.676 . . . . 15.0 109.34 174.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.487 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 36.0 Cg_exo -62.34 134.38 48.18 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.409 2.073 . . . . 15.0 112.159 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.87 126.59 22.18 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.858 2.372 . . . . 15.0 112.174 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 103.93 0.44 45.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.775 -0.726 . . . . 15.0 112.393 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.7 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.5 m95 -89.96 107.53 19.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.83 0.348 . . . . 15.0 111.109 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.674 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 1.1 mp0 -89.98 113.73 25.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.658 -0.867 . . . . 15.0 108.658 172.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.557 HG23 HD11 ' A' ' 296' ' ' ILE . 1.7 p -90.0 101.82 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.536 0.684 . . . . 15.0 110.079 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 1.014 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -90.98 103.01 15.78 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.638 -0.875 . . . . 15.0 108.638 -175.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 46.8 t -90.04 139.86 30.2 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.239 -0.891 . . . . 15.0 109.76 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.8 p -125.6 139.66 53.39 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.904 0.383 . . . . 15.0 111.039 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.2 p -59.73 -15.25 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.238 -0.892 . . . . 15.0 111.768 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 15.9 m -60.76 -14.74 23.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 15.0 111.083 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.07 35.85 7.43 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.365 -0.694 . . . . 15.0 111.365 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.581 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 31.1 ptt180 -141.68 126.04 17.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.53 . . . . 15.0 110.491 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.557 HD11 HG23 ' A' ' 288' ' ' VAL . 0.0 OUTLIER -90.34 137.84 20.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.146 -1.057 . . . . 15.0 108.146 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 1.014 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 1.0 OUTLIER -150.66 136.19 18.01 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.582 -1.266 . . . . 15.0 107.582 -175.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.7 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 1.7 m-85 -94.79 137.76 33.46 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 115.227 1.566 . . . . 15.0 115.227 -166.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.713 HG21 ' O ' ' B' ' 228' ' ' LEU . 26.5 m -130.42 89.66 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 CA-C-N 112.47 -2.15 . . . . 15.0 108.243 178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -90.66 113.47 25.54 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.27 -1.011 . . . . 15.0 108.27 178.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.679 ' CE1' ' HB3' ' B' ' 229' ' ' PRO . 7.9 m170 -84.81 -10.46 57.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.756 -172.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -93.19 -51.31 5.08 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.056 -0.258 . . . . 15.0 111.626 -171.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.58 -14.95 31.48 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.635 -0.506 . . . . 15.0 109.635 174.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.573 ' HG3' ' CE1' ' B' ' 227' ' ' TYR . 45.8 ttt180 64.83 78.17 0.29 Allowed 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.702 0.801 . . . . 15.0 110.93 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.97 150.04 33.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.447 -0.797 . . . . 15.0 110.76 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 11.2 m -116.14 134.4 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.177 -0.465 . . . . 15.0 110.117 176.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.574 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 84.1 mm-40 -134.86 147.89 49.99 Favored 'General case' 0 C--O 1.218 -0.59 0 CA-C-N 116.804 -0.18 . . . . 15.0 111.355 -174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.26 -15.08 18.19 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 121.968 -0.458 . . . . 15.0 111.204 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 3.0 t -88.35 123.66 33.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.133 0.492 . . . . 15.0 111.277 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.19 132.91 20.98 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 15.0 110.218 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.46 -15.01 7.74 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.625 2.217 . . . . 15.0 113.59 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 279' ' ' LEU . 45.8 mtp180 -95.37 -38.56 10.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.988 0.423 . . . . 15.0 110.57 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.07 -0.967 . . . . 15.0 109.418 179.364 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.581 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 15.2 m-20 . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 121.221 0.534 . . . . 15.0 110.973 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.89 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 1.6 p -69.22 175.89 1.88 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.237 -0.892 . . . . 15.0 111.745 -176.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.89 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 4.6 Cg_endo -48.67 139.81 23.41 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 123.19 2.594 . . . . 15.0 113.397 -172.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.521 ' HA ' ' HD3' ' B' ' 225' ' ' PRO . 38.6 Cg_endo -63.77 143.77 87.21 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.389 2.726 . . . . 15.0 114.126 -169.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 11.9 Cg_exo -71.43 -179.99 4.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.749 2.966 . . . . 15.0 111.783 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -67.74 163.8 20.85 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.74 -0.467 . . . . 15.0 109.74 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.661 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -90.08 127.07 35.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.936 0.874 . . . . 15.0 111.436 -175.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.713 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.6 mp -130.04 160.31 65.91 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 107.546 -1.279 . . . . 15.0 107.546 171.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.679 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.7 157.44 7.62 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 120.947 1.098 . . . . 15.0 112.519 -169.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.847 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 40.4 Cg_endo -89.55 146.37 4.96 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.418 2.079 . . . . 15.0 116.56 -146.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.72 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 8.3 pt-20 -108.63 122.64 47.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 113.715 -1.584 . . . . 15.0 108.256 168.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.452 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 24.4 t70 -150.03 128.44 5.97 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 118.285 0.493 . . . . 15.0 110.611 -175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 35.9 Cg_exo -57.79 -73.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.383 2.722 . . . . 15.0 112.357 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.411 -0.359 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 109.815 -0.439 . . . . 15.0 109.815 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.707 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -161.29 97.1 0.15 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.312 -0.947 . . . . 15.0 113.185 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.84 114.45 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.915 2.41 . . . . 15.0 112.215 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.38 116.1 65.59 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.329 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -68.85 133.55 27.56 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.804 2.336 . . . . 15.0 112.043 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.35 123.23 13.14 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.706 2.271 . . . . 15.0 111.627 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 118.57 -5.8 14.47 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.802 -0.713 . . . . 15.0 111.868 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.751 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 8.0 m95 -90.18 113.2 24.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 15.0 110.787 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.748 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.8 mp0 -92.2 120.25 32.6 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.178 -1.045 . . . . 15.0 108.178 172.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 298' ' ' PHE . 2.4 m -90.17 107.17 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 122.215 1.007 . . . . 15.0 109.617 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.664 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -94.29 93.58 7.81 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.479 -0.934 . . . . 15.0 108.479 -177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 1.2 p -102.27 112.26 24.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.874 -0.603 . . . . 15.0 110.847 -177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.0 p -90.42 150.24 21.92 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.011 -0.54 . . . . 15.0 110.927 -177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.67 -15.03 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 115.559 -0.746 . . . . 15.0 112.258 -172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 22.5 p -60.7 -14.48 21.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 15.0 111.314 174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.35 45.09 4.48 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.121 -0.561 . . . . 15.0 112.347 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -140.7 131.04 25.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.944 -0.391 . . . . 15.0 109.944 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 288' ' ' VAL . 17.7 tt -97.32 137.11 25.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.827 -1.175 . . . . 15.0 107.827 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.664 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 4.8 p90 -150.07 133.82 16.78 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.527 -1.286 . . . . 15.0 107.527 -174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.751 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.7 m-85 -89.8 137.69 32.12 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 115.602 1.704 . . . . 15.0 115.602 -163.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.797 HG21 ' O ' ' B' ' 228' ' ' LEU . 30.9 m -134.34 89.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.724 0 CA-C-N 112.121 -2.308 . . . . 15.0 108.595 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.91 116.69 28.17 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.291 -1.374 . . . . 15.0 107.291 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.748 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 9.3 m170 -82.82 -3.32 56.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.787 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -91.51 -64.82 1.07 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.819 0.342 . . . . 15.0 110.929 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.542 HD22 HG23 ' A' ' 305' ' ' THR . 7.9 t30 -85.23 -16.39 40.37 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.567 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 0.3 OUTLIER 66.99 84.0 0.16 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.034 -0.984 . . . . 15.0 111.222 177.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 303' ' ' ASN . 30.2 p -140.15 149.98 43.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.542 -0.754 . . . . 15.0 111.113 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 22.1 p -123.04 121.98 37.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 15.0 110.359 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.24 132.67 20.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 116.617 -0.265 . . . . 15.0 111.49 -174.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -76.12 -14.65 60.18 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.376 0.51 . . . . 15.0 112.376 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 14.3 t -77.94 134.15 37.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.068 0.461 . . . . 15.0 110.921 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.622 ' HB3' HD12 ' A' ' 313' ' ' LEU . 8.9 t70 -116.36 130.5 24.43 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 109.574 -0.528 . . . . 15.0 109.574 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.502 ' HG2' ' HD3' ' A' ' 312' ' ' ARG . 38.2 Cg_endo -67.22 -14.94 44.86 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.017 2.478 . . . . 15.0 114.155 -175.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.707 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 1.1 mpp_? -95.69 -14.93 23.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.028 0.442 . . . . 15.0 110.514 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 310' ' ' ASP . 76.9 mt . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.843 -0.599 . . . . 15.0 110.383 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 109.158 -0.682 . . . . 15.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -86.61 147.73 44.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.623 -0.51 . . . . 15.0 109.623 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 6.4 Cg_endo -48.58 143.65 15.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.459 2.773 . . . . 15.0 113.28 -168.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.416 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.9 Cg_endo -49.34 122.43 8.59 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.667 2.911 . . . . 15.0 113.882 -166.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 49.0 Cg_exo -58.58 179.99 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.859 3.039 . . . . 15.0 112.941 173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.25 161.33 11.48 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.831 -0.622 . . . . 15.0 109.61 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.696 ' HA ' HG12 ' A' ' 299' ' ' VAL . 2.7 p90 -90.04 125.05 35.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.534 -0.866 . . . . 15.0 109.97 -174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.797 ' O ' HG21 ' A' ' 299' ' ' VAL . 3.1 mm? -130.24 160.97 63.06 Favored Pre-proline 0 C--O 1.211 -0.943 0 CA-C-N 115.281 -0.872 . . . . 15.0 109.059 176.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.618 ' HB3' ' HE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.54 160.1 7.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.505 1.47 . . . . 15.0 110.934 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -89.04 129.09 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.633 1.556 . . . . 15.0 115.818 -146.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.93 99.99 7.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.475 -1.693 . . . . 15.0 108.646 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 31.8 t70 -118.1 115.31 36.51 Favored Pre-proline 0 C--N 1.33 -0.28 0 O-C-N 121.552 -0.718 . . . . 15.0 110.869 -175.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.7 Cg_exo -77.66 83.65 2.13 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.072 2.515 . . . . 15.0 111.431 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.169 -0.468 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 279' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.174 -0.676 . . . . 15.0 109.174 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.964 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -113.77 105.89 1.67 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 119.993 -1.099 . . . . 15.0 114.144 -172.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -90.14 114.03 0.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.049 2.5 . . . . 15.0 110.664 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 23.0 tp -98.16 115.69 65.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.675 0.274 . . . . 15.0 110.888 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -62.66 140.32 80.26 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.935 2.423 . . . . 15.0 112.006 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.92 121.91 10.57 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.819 2.346 . . . . 15.0 111.809 177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.36 -3.41 18.28 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.605 -0.807 . . . . 15.0 111.862 -177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.736 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 9.0 m95 -89.41 102.97 15.64 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.343 0.592 . . . . 15.0 111.044 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.702 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -90.09 119.29 30.3 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.04 -1.096 . . . . 15.0 108.04 170.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 298' ' ' PHE . 1.0 OUTLIER -89.93 114.37 27.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.22 -1.03 . . . . 15.0 108.22 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.994 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -105.22 96.96 6.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.362 -0.977 . . . . 15.0 108.362 -177.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.3 p -92.03 131.73 37.09 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.372 -0.831 . . . . 15.0 110.002 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -118.87 148.98 42.31 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.741 -0.384 . . . . 15.0 111.15 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 15.8 t -63.09 -14.94 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.688 -0.687 . . . . 15.0 111.083 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 41.6 t -56.79 -14.62 3.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.775 -0.648 . . . . 15.0 111.553 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.91 32.72 9.63 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -140.84 128.86 21.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.823 0.344 . . . . 15.0 110.509 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.2 tt -89.96 140.69 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.119 -1.437 . . . . 15.0 107.119 167.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.994 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.5 p90 -150.27 132.2 15.16 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.296 -1.372 . . . . 15.0 107.296 -173.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.736 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.2 m-85 -89.81 136.36 33.09 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 114.814 1.413 . . . . 15.0 114.814 -165.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.1 m -136.17 89.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 CA-C-N 112.622 -2.081 . . . . 15.0 108.081 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 305' ' ' THR . 0.0 OUTLIER -91.1 122.37 33.69 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.426 -0.953 . . . . 15.0 108.426 179.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.702 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.52 -19.05 39.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.401 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -77.64 -63.04 1.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.884 0.373 . . . . 15.0 110.571 -173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -86.12 -17.07 36.01 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.83 -0.623 . . . . 15.0 110.296 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 58.2 ttt180 64.72 82.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.204 -0.907 . . . . 15.0 110.79 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.543 HG22 ' OD2' ' A' ' 300' ' ' ASP . 15.1 t -150.06 150.06 31.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.498 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 298' ' ' PHE . 2.5 m -112.29 114.47 27.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.015 -0.538 . . . . 15.0 109.875 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.892 ' HA ' HE21 ' A' ' 307' ' ' GLN . 0.0 OUTLIER -117.15 130.7 56.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.505 -172.143 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.449 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -92.14 -14.68 28.76 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.984 0.421 . . . . 15.0 110.445 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 5.4 t -83.02 119.7 24.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.775 -0.648 . . . . 15.0 110.761 175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.674 ' HB3' HD21 ' A' ' 313' ' ' LEU . 13.8 t70 -96.97 132.06 26.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.359 -0.608 . . . . 15.0 109.359 176.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -87.65 -14.32 3.75 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 123.226 2.617 . . . . 15.0 113.447 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.964 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 18.6 mtp180 -77.32 -14.86 59.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -167.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 310' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.644 -0.693 . . . . 15.0 110.162 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.55 -0.537 . . . . 15.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.6 t -71.57 145.41 90.01 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 110.256 -0.276 . . . . 15.0 110.256 -174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.53 141.03 20.62 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.271 2.648 . . . . 15.0 113.491 -170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.483 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 7.6 Cg_endo -52.6 131.84 42.95 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.755 2.97 . . . . 15.0 114.861 -166.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 224' ' ' PRO . 2.8 Cg_exo -78.48 -179.68 5.68 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 124.788 3.658 . . . . 15.0 112.387 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.26 166.43 9.91 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.898 -0.408 . . . . 15.0 109.898 172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.74 ' HA ' HG12 ' A' ' 299' ' ' VAL . 9.0 p90 -96.2 142.95 27.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.186 0.993 . . . . 15.0 112.294 -174.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.441 ' H ' HG11 ' A' ' 299' ' ' VAL . 6.8 mp -130.21 161.45 60.13 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 113.815 -1.539 . . . . 15.0 109.786 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.461 ' HA ' ' NE2' ' A' ' 301' ' ' HIS . 3.8 Cg_exo -87.53 154.07 7.73 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 120.986 1.124 . . . . 15.0 110.05 174.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.674 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 43.3 Cg_endo -89.55 137.33 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.131 1.887 . . . . 15.0 116.338 -146.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.448 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 10.9 pt-20 -112.17 132.23 55.01 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.633 -1.622 . . . . 15.0 107.439 166.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 33.7 t70 -149.57 111.38 3.41 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 15.0 111.128 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 5.9 Cg_endo -87.47 80.29 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.629 2.886 . . . . 15.0 111.854 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.202 -0.454 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.801 -0.444 . . . . 15.0 109.801 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 281' ' ' PRO . . . 160.81 -38.56 0.43 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.635 -0.793 . . . . 15.0 114.686 -172.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 280' ' ' GLY . 82.1 Cg_endo -89.78 148.11 4.91 Favored 'Trans proline' 0 C--N 1.355 0.91 0 CA-C-N 120.316 2.058 . . . . 15.0 113.596 -172.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 286' ' ' TRP . 40.0 tp -112.74 116.33 47.93 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.136 -0.938 . . . . 15.0 109.849 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 284' ' ' PRO . 17.1 Cg_exo -68.1 134.01 30.48 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.725 2.283 . . . . 15.0 112.515 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 283' ' ' PRO . 50.4 Cg_exo -54.12 120.41 7.91 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.846 2.364 . . . . 15.0 111.787 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.94 -17.02 11.98 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.694 -0.963 . . . . 15.0 110.694 -174.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.723 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 6.8 m95 -89.82 107.3 19.02 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.035 -0.583 . . . . 15.0 109.841 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.709 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -94.21 120.51 34.55 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.574 -0.898 . . . . 15.0 108.574 173.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 2.0 p -89.8 101.11 11.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.46 -177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.929 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -91.29 102.58 15.29 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.948 -1.13 . . . . 15.0 107.948 -177.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 28.5 t -90.99 138.73 31.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.417 -1.265 . . . . 15.0 109.694 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 60.2 p -129.9 136.22 49.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.941 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.66 -15.0 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.651 -0.704 . . . . 15.0 112.13 -172.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 21.5 t -57.33 -14.7 4.89 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.339 0.59 . . . . 15.0 110.64 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 45.02 4.51 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.827 -0.624 . . . . 15.0 112.768 177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 295' ' ' ARG . 0.0 OUTLIER -150.07 138.96 20.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.092 0.472 . . . . 15.0 110.139 171.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 11.3 tt -90.17 142.23 13.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.125 -1.065 . . . . 15.0 108.125 171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.929 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.2 p90 -150.36 129.82 12.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.001 -1.111 . . . . 15.0 108.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.723 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.4 m-85 -90.08 137.17 32.56 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.887 1.44 . . . . 15.0 114.887 -168.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.62 HG21 ' O ' ' B' ' 228' ' ' LEU . 16.4 m -136.36 89.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 CA-C-N 112.153 -2.294 . . . . 15.0 107.949 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -91.46 117.07 29.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.53 -0.915 . . . . 15.0 108.53 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.709 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.2 m170 -80.01 -13.11 59.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.433 -0.803 . . . . 15.0 110.31 -173.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -82.5 -55.77 4.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 15.0 110.881 -175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 29.1 m-80 -91.29 -14.64 30.49 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.008 -0.542 . . . . 15.0 110.781 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 73.76 35.83 0.8 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.881 0.738 . . . . 15.0 109.915 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.404 ' HB ' HE21 ' A' ' 307' ' ' GLN . 74.8 p -107.2 150.06 27.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.24 0.543 . . . . 15.0 112.19 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 8.9 p -121.72 117.2 26.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 15.0 110.252 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 80.9 mm-40 -123.39 140.7 52.74 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.125 -0.488 . . . . 15.0 111.221 -171.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.424 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.2 m-85 -99.37 -14.83 19.01 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.668 -0.645 . . . . 15.0 110.85 171.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 13.5 m -80.24 123.52 28.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.867 -0.606 . . . . 15.0 110.234 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.583 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 24.4 t70 -104.6 126.22 31.94 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.961 0.41 . . . . 15.0 111.026 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.09 -14.7 23.43 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.457 2.771 . . . . 15.0 113.317 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -86.88 -14.95 40.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.787 -0.188 . . . . 15.0 111.433 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.583 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 92.1 mt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.335 -0.841 . . . . 15.0 110.69 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.56 -0.534 . . . . 15.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.546 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 12.2 t -64.88 148.55 97.39 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 110.121 -0.325 . . . . 15.0 110.121 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.546 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.6 Cg_endo -48.44 143.4 15.63 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.47 2.78 . . . . 15.0 113.329 -172.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.753 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 12.2 Cg_endo -54.17 129.03 32.4 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.518 2.812 . . . . 15.0 113.88 -167.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 17.3 Cg_exo -68.29 171.0 13.5 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.583 2.855 . . . . 15.0 112.032 175.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.06 153.6 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.068 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.646 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 7.2 p90 -89.77 135.09 33.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.236 1.017 . . . . 15.0 111.82 -168.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.0 mt -130.18 161.18 61.68 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 113.828 -1.533 . . . . 15.0 108.693 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.44 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.7 Cg_exo -87.78 159.92 7.61 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 120.949 1.099 . . . . 15.0 110.377 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.616 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 59.5 Cg_endo -89.4 143.64 4.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.407 2.072 . . . . 15.0 115.547 -146.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.724 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 12.7 pt-20 -128.16 124.16 36.14 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 113.975 -1.466 . . . . 15.0 109.562 177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.1 99.88 3.24 Favored Pre-proline 0 N--CA 1.451 -0.402 0 O-C-N 121.766 -0.584 . . . . 15.0 110.023 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.4 86.47 1.06 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.287 2.658 . . . . 15.0 112.145 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.261 -0.427 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 46.8 tp . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.4 0.143 . . . . 15.0 110.962 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 135.34 -60.04 0.65 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 119.934 -1.127 . . . . 15.0 114.678 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -89.74 138.07 2.97 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.354 2.036 . . . . 15.0 114.253 -168.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' A' ' 312' ' ' ARG . 54.2 tp -108.93 115.64 56.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 114.985 -1.007 . . . . 15.0 109.693 175.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 6.9 Cg_exo -73.82 132.22 16.8 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.889 2.393 . . . . 15.0 112.689 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.6 125.05 17.83 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.694 2.262 . . . . 15.0 111.821 174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 117.03 -14.28 13.89 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.556 -1.018 . . . . 15.0 110.556 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.739 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.5 m95 -89.85 104.57 17.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.805 -0.698 . . . . 15.0 110.261 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.759 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -89.82 114.86 26.66 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 172.476 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.9 100.01 10.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.487 0.661 . . . . 15.0 110.01 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.887 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -92.6 94.91 9.29 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.543 -0.91 . . . . 15.0 108.543 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.4 p -89.84 143.09 27.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.646 -0.706 . . . . 15.0 109.689 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.4 p -128.3 146.62 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.287 -0.565 . . . . 15.0 111.968 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.23 -14.74 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 114.747 -1.115 . . . . 15.0 111.536 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 295' ' ' ARG . 5.7 m -59.19 -14.83 11.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.332 -0.395 . . . . 15.0 111.271 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 89.9 40.59 5.85 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.524 -0.63 . . . . 15.0 111.524 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 293' ' ' SER . 37.7 ptt180 -150.01 138.75 20.85 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.872 0.368 . . . . 15.0 110.723 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 18.0 tt -100.36 138.12 25.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.442 -0.947 . . . . 15.0 108.442 173.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.887 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.7 p90 -150.53 131.61 14.37 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.207 -1.034 . . . . 15.0 108.207 -174.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.739 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.1 m-85 -92.58 139.15 30.87 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 115.07 1.507 . . . . 15.0 115.07 -167.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.765 HG21 ' O ' ' B' ' 228' ' ' LEU . 33.9 m -131.71 90.05 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.682 -2.054 . . . . 15.0 108.572 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.59 118.83 29.51 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.6 -1.259 . . . . 15.0 107.6 178.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.759 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 10.3 m170 -87.64 -5.13 58.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 15.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 302' ' ' ASN . 0.9 OUTLIER -85.68 -61.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.983 0.421 . . . . 15.0 110.431 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -88.06 -20.64 25.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.953 -0.567 . . . . 15.0 110.56 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 33.5 ttt180 69.46 83.46 0.15 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.502 -0.772 . . . . 15.0 110.32 -175.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 150.12 31.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.605 -0.725 . . . . 15.0 110.439 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.771 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 2.7 m -113.17 122.3 47.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.399 . . . . 15.0 110.294 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 298' ' ' PHE . 14.3 mm100 -122.54 128.43 50.75 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 116.427 -0.351 . . . . 15.0 111.379 -172.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.401 ' HD1' ' HA ' ' A' ' 308' ' ' PHE . 1.1 m-30 -87.17 -14.93 39.82 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 121.898 -0.501 . . . . 15.0 110.862 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 7.0 t -87.4 121.98 30.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.533 . . . . 15.0 110.693 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 313' ' ' LEU . 12.5 t70 -103.27 135.62 19.36 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 15.0 110.334 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.73 -14.75 9.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.955 2.437 . . . . 15.0 113.654 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.517 ' HD2' HD13 ' A' ' 282' ' ' LEU . 53.8 mtp180 -88.29 -20.52 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.957 0.725 . . . . 15.0 112.957 -168.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.489 ' CD2' ' HB3' ' A' ' 310' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.667 -0.682 . . . . 15.0 111.511 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 34.6 m -48.76 131.92 14.36 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 15.0 110.898 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -48.13 143.01 15.06 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.336 2.69 . . . . 15.0 113.272 -170.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.771 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 6.8 Cg_endo -49.34 135.03 32.06 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 124.174 3.249 . . . . 15.0 115.004 -163.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -87.09 -179.61 2.88 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 124.392 3.395 . . . . 15.0 112.511 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.23 150.91 24.34 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.494 -0.321 . . . . 15.0 110.58 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.645 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 6.2 p90 -89.96 128.8 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.91 0.862 . . . . 15.0 111.983 -172.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.765 ' O ' HG21 ' A' ' 299' ' ' VAL . 84.0 mt -130.19 160.78 63.87 Favored Pre-proline 0 C--O 1.214 -0.796 0 CA-C-N 114.886 -1.052 . . . . 15.0 108.642 170.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.656 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.7 Cg_exo -87.5 159.96 8.02 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 121.37 1.38 . . . . 15.0 112.548 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.831 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 45.4 Cg_endo -89.94 154.63 4.91 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.013 2.475 . . . . 15.0 116.34 -145.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -132.35 99.93 4.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.821 -1.536 . . . . 15.0 108.606 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 30.5 t70 -114.98 117.44 41.73 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 121.928 -0.482 . . . . 15.0 111.255 -172.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 9.9 Cg_endo -88.83 84.92 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.547 2.831 . . . . 15.0 112.205 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 116.174 -0.467 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 111.695 0.257 . . . . 15.0 111.695 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.467 ' CA ' ' HA ' ' A' ' 312' ' ' ARG . . . -93.06 -178.6 40.32 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.673 -0.775 . . . . 15.0 112.543 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -89.77 134.3 2.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.07 2.513 . . . . 15.0 112.923 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 312' ' ' ARG . 34.5 tp -110.72 122.24 38.81 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.245 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 282' ' ' LEU . 21.5 Cg_exo -65.6 131.37 27.56 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.913 2.409 . . . . 15.0 112.262 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.32 124.48 13.91 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.702 2.268 . . . . 15.0 111.876 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.83 -4.29 20.91 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.856 -0.688 . . . . 15.0 111.435 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.705 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 7.0 m0 -89.86 116.24 27.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.966 0.412 . . . . 15.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.707 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.8 OUTLIER -95.57 121.39 37.21 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.422 -0.955 . . . . 15.0 108.422 172.314 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.823 ' HB ' HD11 ' A' ' 296' ' ' ILE . 2.5 m -89.87 104.14 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.194 0.997 . . . . 15.0 108.472 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.921 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -93.45 101.95 14.16 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.367 -0.975 . . . . 15.0 108.367 -177.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.6 p -95.08 140.65 29.72 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.966 -1.015 . . . . 15.0 110.735 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 32.2 p -129.06 150.08 50.61 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.514 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.03 -14.96 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.329 -0.851 . . . . 15.0 111.796 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 13.8 p -60.67 -15.01 24.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.442 0.639 . . . . 15.0 110.814 175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.19 44.34 4.74 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.481 -0.781 . . . . 15.0 111.636 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -150.09 134.66 17.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.103 0.478 . . . . 15.0 110.862 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.823 HD11 ' HB ' ' A' ' 288' ' ' VAL . 10.5 tt -90.03 144.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.495 -1.298 . . . . 15.0 107.495 169.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.921 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.29 131.95 14.92 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.544 -1.28 . . . . 15.0 107.544 -174.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.705 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 3.0 m-85 -89.86 135.36 33.68 Favored 'General case' 0 N--CA 1.415 -2.214 0 N-CA-C 115.153 1.538 . . . . 15.0 115.153 -164.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.7 m -140.63 90.29 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.084 0 CA-C-N 111.954 -2.385 . . . . 15.0 108.142 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 304' ' ' ARG . 0.0 OUTLIER -89.92 129.83 36.22 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.636 -1.246 . . . . 15.0 107.636 177.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.707 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 31.5 m170 -84.61 -22.44 29.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.485 -0.78 . . . . 15.0 112.29 -168.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -89.87 -46.09 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.272 -0.571 . . . . 15.0 111.865 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -91.74 -15.0 29.0 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.862 -0.335 . . . . 15.0 110.587 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 45.7 ttp180 57.31 81.92 0.13 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.833 0.708 . . . . 15.0 110.963 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 39.1 p -133.8 150.05 51.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.436 -0.802 . . . . 15.0 111.686 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 10.9 p -123.61 122.84 39.2 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.791 -0.64 . . . . 15.0 111.203 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -141.8 148.61 39.17 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 116.689 -0.232 . . . . 15.0 111.261 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.03 -14.6 18.57 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.677 172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 4.1 t -83.86 122.45 28.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.118 0.485 . . . . 15.0 111.085 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -93.42 118.48 67.6 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 15.0 109.257 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.32 -14.79 44.03 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.327 2.685 . . . . 15.0 113.081 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 282' ' ' LEU . 69.8 mtm180 -88.2 -14.94 37.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.431 -0.35 . . . . 15.0 111.627 -177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.688 -0.673 . . . . 15.0 110.531 -178.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.755 -0.461 . . . . 15.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 9.2 t -51.86 139.47 31.75 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.528 0.518 . . . . 15.0 110.905 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.407 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 5.4 Cg_endo -48.55 137.38 25.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.564 2.843 . . . . 15.0 113.181 -166.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.617 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 9.9 Cg_endo -55.03 128.26 29.81 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.192 2.595 . . . . 15.0 113.986 -166.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 65.6 Cg_exo -55.74 173.22 0.4 Allowed 'Trans proline' 0 N--CA 1.472 0.223 0 C-N-CA 124.082 3.188 . . . . 15.0 112.885 172.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.85 165.3 5.44 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.376 -0.601 . . . . 15.0 109.376 172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.691 ' HA ' HG12 ' A' ' 299' ' ' VAL . 3.3 p90 -89.65 133.29 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 119.301 -0.96 . . . . 15.0 111.191 -171.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.472 ' O ' HG21 ' A' ' 299' ' ' VAL . 92.9 mt -130.27 161.12 62.21 Favored Pre-proline 0 C--N 1.313 -0.978 0 CA-C-N 114.023 -1.444 . . . . 15.0 109.364 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -88.32 153.21 6.69 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 120.859 1.039 . . . . 15.0 109.451 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.473 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 43.9 Cg_endo -89.42 134.91 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.574 1.516 . . . . 15.0 115.436 -149.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.522 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 11.8 pt-20 -101.19 99.91 10.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.557 -1.201 . . . . 15.0 109.171 171.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' B' ' 233' ' ' PRO . 18.7 t70 -136.36 122.53 13.75 Favored Pre-proline 0 C--O 1.235 0.323 0 O-C-N 121.679 -0.638 . . . . 15.0 110.909 -176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 232' ' ' ASP . 51.5 Cg_exo -54.7 -63.95 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.322 2.681 . . . . 15.0 112.585 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.474 -0.33 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 311' ' ' PRO . 62.2 tp . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.457 -0.201 . . . . 15.0 110.457 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 146.44 -74.1 0.3 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.049 -1.072 . . . . 15.0 113.762 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -89.73 141.57 3.85 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.724 2.283 . . . . 15.0 113.996 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 20.7 tp -99.83 121.87 52.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.591 -0.731 . . . . 15.0 109.313 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 33.4 Cg_exo -62.13 142.43 92.03 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.675 2.25 . . . . 15.0 112.15 179.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.23 128.61 23.16 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.775 2.316 . . . . 15.0 112.148 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 107.58 -0.84 34.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 15.0 111.805 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.69 ' HE3' ' CZ ' ' A' ' 298' ' ' PHE . 8.5 m95 -89.84 110.91 21.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.25 0.548 . . . . 15.0 111.615 -176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.66 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 0.3 OUTLIER -98.25 125.85 43.5 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.289 -1.004 . . . . 15.0 108.289 173.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.623 HG12 ' CZ ' ' A' ' 298' ' ' PHE . 33.6 m -89.88 102.62 13.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.587 0.708 . . . . 15.0 109.929 -176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.79 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.89 91.09 8.46 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.314 -1.365 . . . . 15.0 107.314 -179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 29.8 t -95.56 149.99 20.83 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.157 -1.383 . . . . 15.0 109.354 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 47.8 p -135.48 140.59 44.94 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.406 -0.361 . . . . 15.0 110.223 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.98 -14.66 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 15.0 111.103 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 10.2 t -54.3 -14.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.234 -0.894 . . . . 15.0 111.017 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.1 38.08 6.52 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.2 -0.524 . . . . 15.0 112.169 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -150.16 120.14 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.014 0.435 . . . . 15.0 110.858 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.457 HD13 ' N ' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -89.92 138.92 18.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.275 -1.38 . . . . 15.0 107.275 172.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.79 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 3.1 p90 -150.49 132.2 14.95 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.978 -1.119 . . . . 15.0 107.978 -170.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.723 ' O ' ' HA ' ' A' ' 306' ' ' THR . 1.5 m-85 -90.0 131.01 36.12 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 115.251 1.575 . . . . 15.0 115.251 -165.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' B' ' 227' ' ' TYR . 24.1 m -133.29 92.07 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 112.499 -2.137 . . . . 15.0 108.643 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 305' ' ' THR . 0.0 OUTLIER -89.46 125.1 35.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.982 -1.118 . . . . 15.0 107.982 176.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.671 ' HD2' ' CD2' ' B' ' 227' ' ' TYR . 37.1 m170 -82.66 -11.62 58.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.633 -0.712 . . . . 15.0 111.716 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -87.29 -64.9 1.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.945 0.402 . . . . 15.0 110.699 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -90.96 -14.87 30.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.887 -0.597 . . . . 15.0 110.357 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 300' ' ' ASP . 77.2 ttt180 66.38 83.74 0.16 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.936 -1.029 . . . . 15.0 109.791 -166.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 300' ' ' ASP . 30.1 m -112.53 113.68 25.96 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.029 -0.987 . . . . 15.0 109.926 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -110.24 109.6 20.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.099 -0.5 . . . . 15.0 110.914 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 82.1 mt-30 -143.69 138.65 29.06 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.487 -0.324 . . . . 15.0 111.804 -175.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . 0.454 ' HE2' ' O ' ' B' ' 222' ' ' THR . 4.4 m-85 -83.41 -14.96 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.12 -0.362 . . . . 15.0 111.368 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 15.0 t -86.63 139.97 30.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.039 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -117.07 121.69 32.19 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.628 -0.508 . . . . 15.0 109.628 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 279' ' ' LEU . 59.3 Cg_endo -69.42 -14.77 37.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.3 2.666 . . . . 15.0 113.394 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 312' ' ' ARG . 36.4 mtp-105 -67.07 -44.45 80.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.595 0.236 . . . . 15.0 111.249 -178.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.799 HD13 ' H ' ' A' ' 313' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.153 -0.927 . . . . 15.0 110.365 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.402 ' OD2' ' HZ ' ' A' ' 308' ' ' PHE . 24.0 t70 . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 109.77 -0.455 . . . . 15.0 109.77 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.672 ' OG1' ' HD2' ' B' ' 223' ' ' PRO . 5.8 t -56.22 155.57 12.62 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.602 0.564 . . . . 15.0 110.325 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.672 ' HD2' ' OG1' ' B' ' 222' ' ' THR . 4.8 Cg_endo -48.45 145.57 11.74 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.994 2.462 . . . . 15.0 112.868 -173.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.766 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 5.8 Cg_endo -48.8 127.85 17.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.787 2.991 . . . . 15.0 113.908 -165.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 31.4 Cg_exo -61.59 178.36 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 124.08 3.187 . . . . 15.0 113.242 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.66 158.73 14.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.943 -0.762 . . . . 15.0 108.943 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.671 ' CD2' ' HD2' ' A' ' 301' ' ' HIS . 3.2 p90 -91.3 126.88 36.52 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 119.263 -0.975 . . . . 15.0 111.814 -172.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.641 ' O ' HG21 ' A' ' 299' ' ' VAL . 5.8 mp -127.67 160.71 59.35 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-N 113.876 -1.511 . . . . 15.0 107.758 175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.475 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 2.8 Cg_exo -87.86 158.06 7.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 120.997 1.131 . . . . 15.0 110.995 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.716 ' HA ' ' HG2' ' A' ' 289' ' ' ARG . 9.3 Cg_endo -89.52 145.83 4.92 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.399 2.066 . . . . 15.0 115.824 -147.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' B' ' 231' ' ' GLU . 12.5 pt-20 -136.61 99.96 4.21 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.055 -1.429 . . . . 15.0 109.493 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -150.13 117.08 3.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 121.447 -0.783 . . . . 15.0 110.918 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.06 66.5 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.699 2.266 . . . . 15.0 111.947 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.862 -0.608 . . . . 15.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.889 0.376 . . . . 15.0 110.096 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 312' ' ' ARG . . . -85.23 175.86 49.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.859 -0.686 . . . . 15.0 111.88 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -89.74 123.12 1.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.804 2.336 . . . . 15.0 112.905 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 19.9 tp -88.99 116.14 65.49 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.964 -0.562 . . . . 15.0 110.184 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.433 ' HB2' ' CD1' ' A' ' 286' ' ' TRP . 24.1 Cg_exo -64.3 138.48 61.03 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.727 2.284 . . . . 15.0 112.083 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.87 120.92 8.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.104 2.536 . . . . 15.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.55 ' HA3' ' ND2' ' A' ' 302' ' ' ASN . . . 102.76 3.08 49.61 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.806 -0.711 . . . . 15.0 112.45 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.717 ' HE3' ' CE1' ' A' ' 298' ' ' PHE . 5.3 m95 -89.86 107.96 19.41 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-O 120.873 0.368 . . . . 15.0 110.362 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLU . . . . . 0.752 ' HG2' ' CE1' ' A' ' 301' ' ' HIS . 2.7 mp0 -92.3 118.72 31.18 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.574 -0.899 . . . . 15.0 108.574 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 1.6 p -89.93 105.13 15.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.463 0.649 . . . . 15.0 109.524 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.991 ' HD2' ' HE1' ' A' ' 297' ' ' TYR . 0.0 OUTLIER -95.81 91.38 6.03 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.168 -1.049 . . . . 15.0 108.168 -178.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 2.0 p -93.03 121.35 34.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.672 -1.149 . . . . 15.0 110.276 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 46.4 p -103.86 143.03 33.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.305 -0.407 . . . . 15.0 111.098 -175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.32 -14.79 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.495 -0.775 . . . . 15.0 111.582 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' SER . . . . . . . . . . . . . 20.8 t -57.99 -14.5 6.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.981 172.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLY . . . . . . . . . . . . . . . 90.3 41.98 5.35 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.153 -0.546 . . . . 15.0 112.436 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . 0.404 ' HD3' ' OD1' ' B' ' 221' ' ' ASP . 38.4 ptt180 -148.53 128.76 13.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.014 0.435 . . . . 15.0 110.092 177.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 15.9 tt -92.32 137.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.887 -0.783 . . . . 15.0 108.887 175.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.991 ' HE1' ' HD2' ' A' ' 289' ' ' ARG . 2.3 p90 -150.49 130.94 13.81 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.329 -0.989 . . . . 15.0 108.329 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PHE . . . . . 0.717 ' CE1' ' HE3' ' A' ' 286' ' ' TRP . 2.2 m-85 -89.78 137.82 32.01 Favored 'General case' 0 N--CA 1.414 -2.258 0 N-CA-C 115.231 1.567 . . . . 15.0 115.231 -168.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' B' ' 227' ' ' TYR . 15.6 m -135.86 89.48 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.181 -2.282 . . . . 15.0 107.984 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 303' ' ' ASN . 0.0 OUTLIER -93.2 122.49 35.64 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.328 -0.99 . . . . 15.0 108.328 -179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.752 ' CE1' ' HG2' ' A' ' 287' ' ' GLU . 14.5 m170 -82.87 -20.6 35.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.539 -171.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.55 ' ND2' ' HA3' ' A' ' 285' ' ' GLY . 1.5 p30 -93.74 -37.53 11.75 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.986 -0.686 . . . . 15.0 111.73 -170.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASN . . . . . 0.597 ' HB2' ' OD2' ' A' ' 300' ' ' ASP . 34.1 m-80 -91.69 -21.13 20.91 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.762 -0.375 . . . . 15.0 110.342 171.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' B' ' 227' ' ' TYR . 21.9 ttp180 67.35 58.29 0.55 Allowed 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.758 0.661 . . . . 15.0 109.781 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 75.0 p -129.38 150.15 50.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.742 -0.663 . . . . 15.0 111.41 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 224' ' ' PRO . 23.6 p -116.54 132.6 56.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.035 -0.53 . . . . 15.0 110.511 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 298' ' ' PHE . 40.3 mt-30 -141.43 128.3 20.56 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 112.102 0.408 . . . . 15.0 112.102 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -86.78 -14.79 41.24 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.84 -0.537 . . . . 15.0 111.144 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' THR . . . . . . . . . . . . . 1.3 p -89.27 110.97 21.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.147 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.417 ' OD2' ' HG ' ' A' ' 313' ' ' LEU . 20.5 t70 -90.02 134.39 31.83 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.09 -0.505 . . . . 15.0 110.825 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.33 -14.71 10.44 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.329 2.686 . . . . 15.0 113.87 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 280' ' ' GLY . 41.3 mtp180 -92.0 -17.47 25.04 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.118 -0.364 . . . . 15.0 111.684 -173.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.417 ' HG ' ' OD2' ' A' ' 310' ' ' ASP . 87.1 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.245 -0.883 . . . . 15.0 110.361 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.404 ' OD1' ' HD3' ' A' ' 295' ' ' ARG . 8.4 m-20 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 121.147 0.498 . . . . 15.0 110.714 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' B' ' 223' ' ' PRO . 7.8 p -68.95 171.28 6.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.186 -0.916 . . . . 15.0 111.858 -175.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' B' ' 222' ' ' THR . 83.0 Cg_exo -48.7 145.81 12.19 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 123.275 2.65 . . . . 15.0 113.526 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' PRO . . . . . 0.592 ' HB2' ' HB ' ' A' ' 306' ' ' THR . 27.7 Cg_endo -61.5 132.26 39.86 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.358 2.706 . . . . 15.0 113.494 -171.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' PRO . . . . . 0.539 ' HD2' ' CD2' ' A' ' 297' ' ' TYR . 42.2 Cg_exo -61.2 -179.99 0.37 Allowed 'Trans proline' 0 N--CA 1.473 0.266 0 C-N-CA 123.913 3.075 . . . . 15.0 112.791 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.4 164.35 9.31 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 109.549 -0.537 . . . . 15.0 109.549 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' TYR . . . . . 0.721 ' HA ' HG12 ' A' ' 299' ' ' VAL . 5.4 p90 -93.2 136.85 33.09 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.273 1.035 . . . . 15.0 111.952 -171.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 299' ' ' VAL . 6.8 mp -130.05 161.29 60.79 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 113.83 -1.532 . . . . 15.0 108.537 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . 0.45 ' HB3' ' CE1' ' A' ' 301' ' ' HIS . 3.0 Cg_exo -87.74 154.74 7.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 CA-C-N 119.67 0.918 . . . . 15.0 110.201 177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 287' ' ' GLU . 46.0 Cg_endo -89.58 146.66 4.98 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.122 1.881 . . . . 15.0 115.601 -147.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLU . . . . . 0.547 ' HG2' ' HE ' ' A' ' 289' ' ' ARG . 20.0 pt-20 -124.42 110.65 14.79 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.24 -1.346 . . . . 15.0 109.895 178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -149.92 111.86 3.34 Favored Pre-proline 0 N--CA 1.457 -0.121 0 O-C-N 121.61 -0.681 . . . . 15.0 110.197 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.61 75.25 5.14 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.594 2.196 . . . . 15.0 112.392 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.159 -0.473 . . . . 15.0 . . . . . . . . . . 0 0 . 1 stop_ save_